This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BRONCHUS_LUNG_EXALLC for full statistics.
Malignant neoplasm of bronchus and lung
C3_BRONCHUS_LUNG
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
8334 |
4. Check minimum number of eventsNone |
8334 |
5. Include endpointsNone |
8334 |
6. Filter based on genotype QC (FinnGen only) |
8334 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bronchus and lung
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)
- Lung cancer and mesothelioma
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 8334 | 2136 | 6198 |
| Unadjusted period prevalence (%) | 2.22 | 0.73 | 2.73 |
| Median age at first event (years) | 71.66 | 69.18 | 72.51 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 7778
- Matched controls
- 72037
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L01CA04
ATC
vinorelbine; systemic
103.9
323.0
572
55
UGC12
NOMESCO Finland
Flexible bronchoscopy
14.2
323.0
3070
3159
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
3902.7
323.0
1120
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
323.0
467
*
N02AA05
ATC
oxycodone; systemic
3.7
323.0
2342
7552
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
66.2
323.0
956
152
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
145.8
323.0
556
38
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
275.7
323.0
849
32
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
672.4
323.0
666
10
WF004
NOMESCO Finland
Palliative radiotherapy
15.0
323.0
722
489
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
346.9
323.0
462
13
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
153.7
323.0
696
46
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
323.0
832
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
636.5
323.0
330
5
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
617.8
323.0
1380
25
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
297.2
323.0
507
17
Z51.5
ICD-10 Finland
Palliative care
5.1
323.0
1288
2709
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
323.0
580
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
1072.1
323.0
735
7
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
4093.0
323.0
428
*
130
Kela drug reimbursment
Malignant tumour
16.6
323.0
3439
3279
GDC00
NOMESCO Finland
Lobectomy of lung
151.7
323.0
591
39
A04AA01
ATC
ondansetron; systemic, rectal
6.9
323.0
1165
1801
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
464.7
323.0
973
22
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
323.0
2891
8189
H02AB02
ATC
dexamethasone; systemic
8.4
323.0
2236
3297
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
56.2
323.0
2423
575
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
17.6
323.0
891
526
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
131.4
323.0
926
74
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
16.6
323.0
3915
4132
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
113.0
323.0
438
38
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
323.0
1198
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
323.0
2468
7658
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
236.3
323.0
365
15
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
493.6
323.0
901
19
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
88.4
323.0
835
98
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
561.3
323.0
866
16
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
323.0
760
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
4694.7
323.0
1656
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
323.0
985
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.3
323.0
1121
1885
WF049
NOMESCO Finland
Radiotherapy of metastasis
10.8
323.0
992
962
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
323.0
348
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.1
312.8
830
1190
A98
ICPC
Health maint/preventive medicine
0.4
300.3
3789
50439
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
23.8
292.3
434
178
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
915.1
284.8
286
*
R84
ICPC
Malignant neoplasm bronchus/lung
98.7
280.1
317
31
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
456.1
279.6
286
6
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
526.1
270.0
275
5
GD1AD
NOMESCO Finland
Thorax CT examination
5.9
265.4
805
1371
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
151.0
260.4
283
18
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
31.3
257.7
355
110
8010/3-C34.9
ICD-O-3
Carcinoma, NOS, of lung, NOS
+∞
256.4
252
*
L01CB01
ATC
etoposide; systemic
73.4
253.0
297
39
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
15.7
241.8
415
258
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
8.7
241.5
556
632
R03BB04
ATC
tiotropium bromide; inhalant
2.9
229.7
1662
6139
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
554.3
229.0
233
*
JN4BD
NOMESCO Finland
Extensive body CT
3.1
219.4
1415
4821
TGD00
NOMESCO Finland
Needle biopsy of lung
50.5
216.3
269
51
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
1007.8
211.2
212
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.4
207.7
829
1895
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
625.5
195.2
198
*
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
919.9
192.9
194
*
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
370.0
189.9
196
5
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
360.2
184.9
191
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
181.7
3084
17296
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.5
177.2
566
1011
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
32.9
175.3
238
69
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
33.8
173.4
234
66
8000/3-C34.1
ICD-O-3
Neoplasm, malignant of upper lobe, lung
+∞
169.6
167
*
WF002
NOMESCO Finland
Radical radiotherapy
3.9
168.0
768
1974
A04AA55
ATC
palonosetron, combinations; systemic
8.8
164.8
373
408
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
371.0
153.1
158
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.9
152.4
1061
3727
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
44.2
150.0
191
41
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
6.5
146.5
406
603
WZC30
NOMESCO Finland
Teaching
2.6
145.1
1199
4665
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.7
144.0
1105
4113
A04AA02
ATC
granisetron; systemic, transdermal
3.9
143.8
657
1680
191
Kela drug reimbursment
Erlotinib
69.6
143.1
169
23
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
143.1
141
*
H02AB06
ATC
prednisolone; systemic
1.8
140.9
3798
24545
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.8
139.9
652
1695
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
441.3
137.5
141
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.4
135.6
725
2105
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.4
132.4
524
1171
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.2
128.8
428
795
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.3
128.4
326
427
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
74.6
128.3
150
19
155
Kela drug reimbursment
Afatinib and gefitinib
610.6
128.0
130
*
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
211.9
127.2
135
6
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
119.1
125.3
139
11
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
208.8
125.2
133
6
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
596.2
125.0
127
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
9.3
124.8
272
278
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.5
121.8
221
156
5826
FHL
Lobectomy or bilobectomy
73.4
119.5
140
18
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
117.3
1051
4238
R04.2
ICD-10 Finland
Haemoptysis
3.8
116.3
544
1412
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.2
116.3
664
2016
L01XE03
ATC
[U] erlotinib; oral
64.4
114.9
137
20
N02AA01
ATC
morphine; systemic, rectal
6.3
113.9
322
490
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
143.4
111.9
122
8
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
348.4
108.3
112
*
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
+∞
106.4
105
*
JN4AD
NOMESCO Finland
Body CT examination
2.7
105.3
812
2996
GDD00
NOMESCO Finland
Pneumonectomy
256.9
103.9
109
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.3
103.0
410
918
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
102.8
3556
23933
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
32.7
102.6
139
40
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.9
102.4
462
1160
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
7.3
101.2
256
333
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
70.0
101.0
119
16
J01MA14
ATC
moxifloxacin; systemic
2.5
98.3
888
3573
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
97.9
2099
28030
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
239.5
96.9
102
*
8000/3-C34.3
ICD-O-3
Neoplasm, malignant of lower lobe, lung
+∞
96.3
95
*
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
232.1
93.9
99
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.5
93.8
1407
20659
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
+∞
93.2
92
*
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.2
89.4
294
538
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
89.3
1729
23845
J93.8
ICD-10 Finland
Other pneumothorax
16.4
88.8
148
85
R03BB01
ATC
ipratropium bromide; inhalant
2.6
87.7
714
2707
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.2
86.4
354
813
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
86.2
474
1392
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.6
85.1
1380
19967
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
35.1
84.1
112
30
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
83.0
3173
37695
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.5
82.3
311
660
L01XE13
ATC
[U] afatinib; oral
+∞
82.1
81
*
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
22.9
82.0
122
50
N06DX01
ATC
memantine; oral
0.2
80.7
118
4354
1BA04
NOMESCO Finland
NA
73.5
80.4
94
12
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.4
80.4
314
689
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
80.3
756
3093
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.1
79.9
270
509
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
381.6
79.6
82
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.0
79.6
502
1622
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
12.6
79.5
148
111
GDC10
NOMESCO Finland
Bilobectomy of lung
747.2
79.2
80
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
79.2
696
2744
A06AH03
ATC
naloxegol; oral
7.2
78.3
199
261
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
8.7
77.6
175
190
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
77.2
1132
5645
N07BA03
ATC
varenicline; oral
4.0
77.2
333
801
R03AC02
ATC
salbutamol; inhalant
1.6
77.0
3373
23515
ZX050
NOMESCO Finland
Stereotactic radiotherapy
9.7
76.8
163
159
C34.17
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary carcinoid
718.8
76.2
77
*
C34.37
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung carcinoid
718.8
76.2
77
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
76.1
1477
8155
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
74.9
1046
15852
GEA00
NOMESCO Finland
Mediastinoscopy
22.4
74.8
112
47
P20
ICPC
Memory disturbance
0.4
74.2
352
7551
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
74.1
1376
19398
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.5
74.0
726
12167
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
15.1
73.9
127
79
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
14.3
73.4
129
85
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
72.0
1627
9418
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
71.3
2073
12920
N02AX02
ATC
tramadol; systemic, rectal
1.6
70.7
3189
22226
ZX120
NOMESCO Finland
Intravenous
2.2
70.6
828
3749
1240
FHL
Bronchoscopy
5.0
70.0
239
456
A04AD12
ATC
aprepitant; systemic
6.1
69.9
201
313
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
69.4
840
13283
TGA30
NOMESCO Finland
Thoracocentesis
6.7
68.5
183
258
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.6
68.1
1541
20829
SPAT1053
SPAT
Memory test
0.5
68.0
535
9631
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
19.5
67.9
106
51
3004
Kela drug reimbursment
Osimertinib
+∞
67.9
67
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
25.2
67.3
97
36
J01MA12
ATC
levofloxacin; systemic
1.7
66.3
1674
9980
1625A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]
624.3
66.1
67
*
8140/3-C34.2
ICD-O-3
Adenocarcinoma, NOS, of middle lobe, lung
+∞
65.8
65
*
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
13.0
65.6
120
87
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
65.0
1239
6760
WX250
NOMESCO Finland
Intercostal blockade
26.1
64.4
92
33
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
18.9
64.1
101
50
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
96.1
63.8
72
7
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.6
63.4
1599
21181
K02.1
ICD-10 Finland
Caries of dentine
0.6
63.3
1557
20739
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
62.1
678
2965
341
Kela drug reimbursment
Afatinib and gefitinib
586.6
62.0
63
*
8250/3-C34.9
ICD-O-3
Lepidic adenocarcinoma of lung, NOS
+∞
61.8
61
*
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
8.4
61.0
140
157
1519
Kela drug reimbursment
NA
+∞
60.8
60
*
SPAT1325
SPAT
Vaccination
0.6
60.5
1393
18872
XKD00
NOMESCO Finland
Uroflowmetry
0.5
59.9
755
11867
R03DA04
ATC
theophylline; systemic, rectal
2.0
58.0
778
3715
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
9.4
57.8
124
124
C34.85
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary other non-microcellular carcinoma
+∞
57.7
57
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
57.5
565
9543
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
57.5
133
3901
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
539.5
57.0
58
*
L03AA13
ATC
pegfilgrastim; parenteral
3.3
56.9
305
877
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.3
56.8
312
913
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
+∞
56.7
56
*
S18
ICPC
Laceration/cut
0.6
56.6
1607
20884
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
56.6
766
11838
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.5
56.4
682
10864
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.0
55.9
239
571
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
24.9
55.4
80
30
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.9
55.1
131
156
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
53.9
478
8338
1623B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]
+∞
53.7
53
*
C10AA05
ATC
atorvastatin; oral
0.7
53.1
1763
22267
L01EB04
ATC
osimertinib; oral
+∞
52.6
52
*
KMAK
NOMESCO Finland
NA
0.6
52.5
1441
18925
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.8
52.2
184
364
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
13.1
51.9
94
67
8551/3-C34.1
ICD-O-3
Acinar cell cystadenocarcinoma of upper lobe, lung
+∞
51.6
51
*
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.6
51.6
1042
14636
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.6
51.6
700
10836
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
12.2
50.7
95
73
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
50.7
979
13905
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
+∞
50.6
50
*
J94.8
ICD-10 Finland
Other specified pleural conditions
3.6
50.4
242
639
C34.14
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma
167.8
50.3
54
*
TGC00
NOMESCO Finland
Bronchial lavation
3.2
50.2
276
809
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
6.5
50.1
136
197
8070/3-C34.0
ICD-O-3
Squamous cell carcinoma, NOS, of main bronchus
+∞
49.6
49
*
SPAT1301
SPAT
No procedures
0.6
49.1
1175
15929
Z01.2
ICD-10 Finland
Dental examination
0.6
49.0
960
13604
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.5
48.8
242
655
SPAT1153
SPAT
Removal of sutures
0.6
48.7
1124
15361
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.1
48.5
124
165
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
100.7
48.2
54
5
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.7
47.2
142
235
1CD01
NOMESCO Finland
NA
21.4
47.1
71
31
L57.0
ICD-10 Finland
Actinic keratosis
0.4
47.1
260
5318
C34.26
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
445.4
46.9
48
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
46.7
129
3494
SPAT1312
SPAT
General health counselling
0.6
46.6
919
13027
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.0
46.6
287
911
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.6
46.6
1374
17873
8041/3-C34.0
ICD-O-3
Small cell carcinoma, NOS, of main bronchus
+∞
46.6
46
*
8240/3-C34.3
ICD-O-3
Neuroendocrine tumor, NOS, of lower lobe, lung
+∞
46.6
46
*
H13
ICPC
Plugged feeling ear
0.5
46.3
549
8840
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
46.1
356
6504
N06DA02
ATC
donepezil; oral
0.3
45.5
133
3513
R85
ICPC
Malignant neopl respiratory other
26.0
45.0
64
23
C34.33
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma
426.6
44.9
46
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.5
44.7
533
8572
5828
FHL
Pneumectomy
218.9
44.6
47
*
SPAT1310
SPAT
Counselling related to known health issue
0.6
44.6
1006
13857
C34.34
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma
+∞
44.5
44
*
C10AA07
ATC
rosuvastatin; oral
0.6
44.5
732
10842
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
44.5
416
7171
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
44.3
462
1969
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
12.4
44.2
82
62
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.5
43.2
159
330
G04CA02
ATC
tamsulosin; oral
0.7
43.1
1676
20757
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
42.8
345
6231
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.8
42.7
188
462
SDA02
NOMESCO Finland
Parodonthologic therapy
0.6
42.7
751
10955
WX892
NOMESCO Finland
Monitored bed care
1.9
42.5
635
3149
B01AB05
ATC
enoxaparin; parenteral
1.5
42.4
2094
14446
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.6
42.1
153
314
N02BE01
ATC
paracetamol; systemic, rectal
0.7
41.7
4702
49112
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.5
41.5
454
7491
D82
ICPC
Teeth/gum disease
0.6
41.4
726
10609
SPAT1249
SPAT
Treatment-related counselling outside office
0.7
41.2
1376
17560
J01DB01
ATC
cefalexin; oral
0.7
40.7
4063
43343
PJD99
NOMESCO Finland
Excision of other lymph nodes
33.6
40.6
54
15
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.7
40.5
1819
22025
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
8.1
40.4
94
109
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.7
40.4
1615
19954
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
379.6
39.9
41
*
N06DA03
ATC
rivastigmine; oral, transdermal
0.2
39.8
60
2193
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.9
39.7
252
817
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
8.3
39.2
90
102
J93.9
ICD-10 Finland
Pneumothorax, unspecified
7.1
39.1
99
131
L01XE02
ATC
[U] gefitinib; oral
370.2
38.9
40
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.7
38.6
1691
20607
WW200
SPAT
NA
0.3
38.5
86
2571
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
38.5
508
2396
GD002
NOMESCO Finland
Radical radiotherapy of trachea, bronchi and lungs
360.8
37.9
39
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
37.9
459
2091
ZX095
NOMESCO Finland
Combined chemoradiotherapy
8.4
37.9
86
96
SPAT1263
SPAT
Sampling
0.7
37.8
1639
20021
C09CA01
ATC
losartan; oral
0.6
37.7
879
12084
L15
ICPC
Knee symptom/complaint
0.6
37.6
462
7399
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
351.4
36.9
38
*
D19
ICPC
Teeth/gum symptom/complaint
0.6
36.7
485
7623
8070/3-C34.2
ICD-O-3
Squamous cell carcinoma, NOS, of middle lobe, lung
+∞
36.4
36
*
C34.97
ICD-10 Finland
Malignant tumor in unspecified location in bronchial and pulmonary carcinoid
+∞
36.4
36
*
SPAT1043
SPAT
Audiometry
0.5
36.4
263
4926
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
36.4
1286
16315
B01AB10
ATC
tinzaparin; parenteral
2.0
36.3
498
2387
N03AX16
ATC
pregabalin; oral
1.5
36.2
1460
9599
K03.64
ICD-10 Finland
Dental calculus supragingival
0.6
36.1
477
7495
JN4CD
NOMESCO Finland
Very extensive body CT
2.3
36.0
354
1467
M79.6
ICD-10 Finland
Pain in limb
0.7
36.0
1131
14664
F03
ICD-10 Finland
Unspecified dementia
0.4
35.9
126
3079
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.4
35.8
134
284
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
35.7
1489
9857
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.3
35.6
77
2342
1BC05
NOMESCO Finland
NA
76.4
35.6
41
5
8046/3-C34.9
ICD-O-3
Non-small cell carcinoma of lung, NOS
+∞
35.4
35
*
Z72.0
ICD-10 Finland
Tobacco use
3.5
35.3
170
451
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.2
35.2
396
1745
L17
ICPC
Foot/toe symptom/complaint
0.6
35.2
747
10494
G04BD12
ATC
mirabegron; oral
0.5
35.1
238
4552
M01AH05
ATC
etoricoxib; oral
0.7
35.0
2002
23450
1629X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]
332.6
34.9
36
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.5
34.9
338
5789
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.6
34.7
534
8085
3001
Kela drug reimbursment
Alectinib
+∞
34.4
34
*
8480/3-C34.3
ICD-O-3
Mucinous adenocarcinoma of lower lobe, lung
+∞
34.4
34
*
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
34.2
1045
6429
H02
ICPC
Hearing complaint
0.5
34.1
353
5931
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
0.5
34.0
294
5209
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
33.8
1024
13397
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.6
33.7
510
7752
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.5
33.5
234
4437
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
33.5
387
6309
1504
Kela drug reimbursment
Alectinib
+∞
33.4
33
*
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.4
33.3
137
3141
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.6
33.2
617
8936
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.4
33.1
138
3145
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
33.0
1429
9512
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
21.7
32.9
49
21
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.6
32.7
155
407
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.6
32.6
523
7850
A79
ICPC
Malignancy NOS
3.6
32.6
151
389
C10AA01
ATC
simvastatin; oral
0.7
32.4
2655
29597
8010/3-C34.3
ICD-O-3
Carcinoma, NOS, of lower lobe, lung
+∞
32.4
32
*
8551/3-C34.3
ICD-O-3
Acinar cell cystadenocarcinoma of lower lobe, lung
+∞
32.4
32
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
32.4
1482
18047
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
51.8
32.0
39
7
B01AF01
ATC
rivaroxaban; oral
0.5
31.8
310
5302
B02AA02
ATC
tranexamic acid; systemic
1.7
31.7
733
4179
L01XX17
ATC
[U] topotecan; systemic
158.1
31.7
34
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
19.0
31.6
49
24
8240/3-C34.1
ICD-O-3
Neuroendocrine tumor, NOS, of upper lobe, lung
+∞
31.4
31
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.3
31.3
61
1949
G04CB02
ATC
dutasteride; oral
0.5
31.0
261
4667
G20
ICD-10 Finland
Parkinson disease
0.2
30.9
44
1660
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
16.6
30.7
50
28
L03AA14
ATC
lipegfilgrastim; parenteral
3.8
30.7
134
329
Z00.0
ICD-10 Finland
General medical examination
0.6
30.6
534
7862
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.8
30.6
133
325
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
31.8
30.6
41
12
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.1
30.4
124
286
G04CA01
ATC
alfuzosin; oral
0.6
30.4
561
8158
8046/3-C34.1
ICD-O-3
Non-small cell carcinoma of upper lobe, lung
+∞
30.4
30
*
7866A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest
17.9
30.3
48
25
R4110
NOMESCO Finland
Physiotherapy
1.4
30.1
1694
11845
D01BA02
ATC
terbinafine; oral; topical
0.7
30.1
860
11408
5188X
ICD-9 Finland
Other diseases of lung
6.6
30.1
79
111
J86.9
ICD-10 Finland
Pyothorax without fistula
4.2
30.0
117
259
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.5
29.9
236
4304
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
29.8
873
11531
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.6
29.8
401
6291
R95
ICPC
Chron obstructive pulmonary disease
2.3
29.7
277
1119
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
12.6
29.6
54
40
M01AX05
ATC
glucosamine; oral
0.6
29.4
730
9965
GAA31
NOMESCO Finland
Thoracoscopy
8.7
29.4
65
70
ZX080
NOMESCO Finland
Image guided radiotherapy
3.2
29.4
159
463
8041/3-C34.2
ICD-O-3
Small cell carcinoma, NOS, of middle lobe, lung
+∞
29.3
29
*
L01XE35
ATC
[U] osimertinib; oral
+∞
29.3
29
*
J43.9
ICD-10 Finland
Emphysema, unspecified
2.7
29.2
203
699
1628A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]
280.9
28.9
30
*
C08CA01
ATC
amlodipine; oral
0.7
28.4
1809
21029
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
14.3
28.4
49
32
H25.1
ICD-10 Finland
Senile nuclear cataract
0.7
28.4
1540
18332
L01ED03
ATC
alectinib; oral
+∞
28.3
28
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
5.0
28.3
94
177
L13
ICPC
Hip symptom/complaint
0.6
28.3
409
6306
L03AA02
ATC
filgrastim; parenteral
2.7
28.2
205
724
VALMI
NOMESCO Finland
NA
0.6
27.9
483
7133
N05AX08
ATC
risperidone; systemic
0.5
27.9
211
3905
XG460
NOMESCO Finland
Short time oxymetry
2.6
27.9
209
750
1625X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]
139.4
27.7
30
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
139.4
27.7
30
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.1
27.7
324
1454
1622A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]
+∞
27.3
27
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
0.6
27.2
434
6538
R06.0
ICD-10 Finland
Dyspnoea
1.4
27.2
1762
12598
N05CF01
ATC
zopiclone; oral
1.3
27.2
2409
18116
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
7.0
27.1
68
90
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
15.5
27.0
45
27
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
36.2
27.0
35
9
G47.3
ICD-10 Finland
Sleep apnoea
0.6
26.9
554
7876
169
Kela drug reimbursment
Crizotinib
261.5
26.9
28
*
1625B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MICROCELLURE]
261.5
26.9
28
*
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
261.5
26.9
28
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.7
26.9
1173
14476
B01AF02
ATC
apixaban; oral
0.5
26.9
296
4901
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.0
26.5
110
259
H81
ICPC
Excessive ear wax
0.6
26.5
614
8517
UKC02
NOMESCO Finland
Cystoscopy
0.7
26.4
849
11051
WW500
NOMESCO Finland
Blood transfusion
2.1
26.4
318
1443
L01EB03
ATC
afatinib; oral
+∞
26.3
26
*
C34.27
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung carcinoid
+∞
26.3
26
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
26.3
689
9320
Z51.0
ICD-10 Finland
Radiotherapy session
3.4
26.2
132
365
GAC00
NOMESCO Finland
Biopsy of pleura
5.4
26.1
80
138
DAX08
NOMESCO Finland
Fitting of hearing aid
0.3
26.0
79
2053
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.3
26.0
57
1720
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.7
26.0
840
10925
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.0
25.9
86
162
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.7
25.9
1227
14959
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.7
25.9
756
10020
T90
ICPC
Diabetes non-insulin dependent
0.7
25.7
920
11750
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.4
25.3
126
346
8010/3-C34.1
ICD-O-3
Carcinoma, NOS, of upper lobe, lung
+∞
25.3
25
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.5
25.2
213
3811
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
0.7
25.2
773
10155
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.3
25.2
244
1006
-1
NOMESCO Finland
NA
0.7
25.1
823
10688
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
2.6
25.1
190
689
WX330
NOMESCO Finland
Paravertebral ansthesia
67.5
24.9
29
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
5.0
24.8
82
154
207
Kela drug reimbursment
Chronic arrhythmias
0.7
24.8
677
9093
S29
ICPC
Skin symptom/complaint other
0.6
24.8
465
6752
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
25.0
24.7
35
13
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.6
24.7
481
6925
A06AC01
ATC
ispaghula (psylla seeds); oral
0.7
24.6
889
11349
L03
ICPC
Low back symptom/complaint
0.6
24.6
603
8275
J01AA02
ATC
doxycycline; systemic
1.3
24.5
5181
43652
M05BX04
ATC
denosumab; parenteral
2.0
24.3
341
1646
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
24.3
69
1845
8246/3-C34.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of lung, NOS
+∞
24.3
24
*
1623G
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,VAIN SYTOL DG]
+∞
24.3
24
*
C34.84
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary macrocellular anaplastic carcinoma
+∞
24.3
24
*
C34.05
ICD-10 Finland
Malignant tumor of the main bronchial other non-microcellular carcinoma
+∞
24.3
24
*
8250/3-C34.1
ICD-O-3
Lepidic adenocarcinoma of upper lobe, lung
+∞
24.3
24
*
L01XE36
ATC
[U] alectinib; oral
+∞
24.3
24
*
WX110
NOMESCO Finland
Local anesthesy
0.8
24.1
2769
29965
R42
ICD-10 Finland
Dizziness and giddiness
0.7
24.1
863
11036
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.8
24.1
160
537
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.0
24.0
143
445
JN6AD
NOMESCO Finland
CT of torso and neck
3.7
24.0
107
269
SPAT1097
SPAT
Recording of ECG
0.6
24.0
501
7109
DFF00
NOMESCO Finland
Pure tone audiometry
0.5
24.0
212
3741
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.4
23.9
204
787
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.4
23.7
87
2089
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
23.6
1590
11403
8250/3-C34.3
ICD-O-3
Lepidic adenocarcinoma of lower lobe, lung
+∞
23.3
23
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
10.7
23.1
45
39
I50.0
ICD-10 Finland
Congestive heart failure
0.6
23.1
374
5621
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
0.6
23.1
553
7631
J01FA06
ATC
roxithromycin; oral
1.3
23.0
2457
18870
SPAT1304
SPAT
Counselling and guidance related to ageing
0.5
22.7
217
3743
P70
ICPC
Dementia
0.2
22.6
25
1084
L08
ICPC
Shoulder symptom/complaint
0.6
22.6
497
6983
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.3
22.6
50
1499
205
Kela drug reimbursment
Chronic hypertension
0.8
22.5
1793
20364
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.5
22.4
229
3875
L01XE16
ATC
[U] crizotinib; oral
+∞
22.3
22
*
8000/3-C34.0
ICD-O-3
Neoplasm, malignant of main bronchus
+∞
22.3
22
*
C10AX09
ATC
ezetimibe; oral
0.6
22.2
270
4363
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
6.0
22.2
62
96
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
22.0
346
1744
325
Kela drug reimbursment
Erlotinib
111.4
21.9
24
*
SPAT1216
SPAT
Assessment of functional ability
0.7
21.8
626
8344
GDA10
NOMESCO Finland
Biopsy of lung
9.1
21.7
46
47
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
0.5
21.6
178
3211
K86
ICPC
Hypertension uncomplicated
0.6
21.6
352
5284
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
21.5
583
7858
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
0.6
21.5
371
5497
SFA00
NOMESCO Finland
Small filling
0.5
21.5
229
3828
116
Kela drug reimbursment
Prostate cancer
0.6
21.5
324
4957
M25.5
ICD-10 Finland
Pain in joint
0.7
21.4
717
9296
K78
ICPC
Atrial fibrillation/flutter
0.6
21.3
283
4467
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.7
21.1
568
7669
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.5
21.1
228
3802
M16.1
ICD-10 Finland
Other primary coxarthrosis
0.6
21.1
383
5612
R01AD12
ATC
fluticasone furoate; nasal
0.7
21.1
596
7975
SFA40
NOMESCO Finland
Replacement of krone of tooth
0.7
21.0
578
7772
I50.9
ICD-10 Finland
Heart failure, unspecified
0.7
21.0
878
10963
M54.5
ICD-10 Finland
Low back pain
0.7
21.0
974
11963
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
6.9
20.9
53
72
B01AB04
ATC
dalteparin; parenteral
1.8
20.8
364
1902
C09CA06
ATC
candesartan; oral
0.7
20.6
659
8623
XJH00
NOMESCO Finland
Transanal ultrasonography
0.6
20.6
306
4701
A06AD11
ATC
lactulose; oral
1.4
20.6
1336
9492
SAA03
NOMESCO Finland
Extended examination of mouth
0.7
20.5
1071
12929
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
11.8
20.5
38
30
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.4
20.5
115
2350
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.5
20.4
188
3280
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.6
20.4
324
4897
1623E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA ALIA DEF/NUD]
+∞
20.2
20
*
C34.83
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary bronchoalveolar carcinoma
+∞
20.2
20
*
GD003
NOMESCO Finland
Adjuvant radiotherapy of trachea, bronchi and lungs
+∞
20.2
20
*
8140/3-C34.0
ICD-O-3
Adenocarcinoma, NOS, of main bronchus
+∞
20.2
20
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.8
20.2
1544
17679
J01MA02
ATC
ciprofloxacin; systemic
0.8
20.1
2001
22173
R03AC13
ATC
formoterol; inhalant
1.8
20.0
354
1857
R31
ICD-10 Finland
Unspecified haematuria
0.6
19.9
483
6660
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
4.7
19.9
68
134
H26.4
ICD-10 Finland
After-cataract
0.6
19.7
320
4808
UGC02
NOMESCO Finland
Rigid bronchoscopy
8.2
19.6
44
50
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
15.7
19.5
32
19
R33
ICD-10 Finland
Retention of urine
0.6
19.4
418
5907
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.5
19.4
124
2422
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.6
19.4
228
3713
G30.8
ICD-10 Finland
Other Alzheimer disease
0.3
19.4
37
1195
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
19.2
1378
15936
C34.87
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary carcinoid
+∞
19.2
19
*
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
+∞
19.2
19
*
SPAT1260
SPAT
Consultation of another employee
0.7
19.2
546
7301
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
19.2
2678
21156
SPAT1305
SPAT
Counselling and guidance related to physical exercise
0.6
19.1
231
3739
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.6
19.0
243
3877
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
0.5
19.0
174
3039
UJF32
NOMESCO Finland
Coloscopy
0.7
19.0
1096
13057
1629A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA EPIDERMOIDES]
185.6
19.0
20
*
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
97.5
18.9
21
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
0.6
18.9
260
4072
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
13.3
18.9
33
23
A04AA03
ATC
tropisetron; systemic
6.9
18.8
47
63
S01ED51
ATC
timolol, combinations; ophthalmic
0.6
18.7
246
3894
A10BA02
ATC
metformin; oral
0.8
18.7
1410
16206
H61.2
ICD-10 Finland
Impacted cerumen
0.5
18.7
110
2209
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.0
18.7
76
178
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.2
18.7
101
298
C09AA02
ATC
enalapril; systemic
0.7
18.6
1093
12994
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.6
18.6
268
4148
WX600
NOMESCO Finland
Single shot through catheter
3.7
18.4
81
203
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
3.7
18.3
82
209
HMAK
NOMESCO Finland
NA
0.5
18.3
198
3297
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
0.6
18.3
211
3454
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
15.5
18.3
30
18
C34.25
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other non-microcellular carcinoma
+∞
18.2
18
*
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.5
18.0
161
2832
ZYC01
SPAT
NA
0.3
17.8
40
1190
I87.1
ICD-10 Finland
Compression of vein
12.4
17.8
32
24
C08CA13
ATC
lercanidipine; oral
0.7
17.7
441
6055
SPAT1109
SPAT
Analgesia with portable analgesic pump
3.9
17.6
73
174
WX320
NOMESCO Finland
Spinalanesthesy
0.7
17.6
855
10462
A02BA02
ATC
ranitidine; systemic
1.3
17.6
1467
10806
R03AC12
ATC
salmeterol; inhalant
1.7
17.6
399
2259
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
0.5
17.6
165
2863
GDB10
NOMESCO Finland
Wedge resection of lung
9.1
17.5
37
38
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
0.7
17.5
480
6468
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.7
17.4
598
7735
GCA02
NOMESCO Finland
Bronchoscopic electrocoagulation of lesion of bronchus
48.7
17.3
21
*
B01AA03
ATC
warfarin; systemic
0.8
17.2
1404
16008
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
0.7
17.2
841
10283
1625C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]
+∞
17.2
17
*
8020/3-C34.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of lung, NOS
+∞
17.2
17
*
8046/3-C34.3
ICD-O-3
Non-small cell carcinoma of lower lobe, lung
+∞
17.2
17
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
17.2
978
6780
R05CB01
ATC
acetylcysteine; inhalant, oral
2.2
17.1
183
793
H91.1
ICD-10 Finland
Presbycusis
0.6
17.1
231
3632
Z97.4
ICD-10 Finland
Presence of external hearing-aid
0.5
17.0
152
2674
K85
ICPC
Elevated blood pressure
0.7
16.9
501
6653
A97
ICPC
No disease
0.7
16.9
427
5843
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
2.8
16.7
109
365
SPAT1149
SPAT
Suture or treatment of traumatic wound
0.7
16.7
435
5926
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
0.7
16.6
705
8810
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.6
16.5
223
3510
H40.0
ICD-10 Finland
Glaucoma suspect
0.5
16.5
170
2875
OAB42
SPAT
NA
0.3
16.4
38
1111
C09AA05
ATC
ramipril; oral
0.8
16.4
1377
15658
GDB20
NOMESCO Finland
Segmental resection of lung
29.2
16.4
22
7
R35
ICD-10 Finland
Polyuria
0.5
16.3
180
2984
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.6
16.2
196
3171
C34.23
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma
+∞
16.2
16
*
8013/3-C34.9
ICD-O-3
Large cell neuroendocrine carcinoma of lung, NOS
+∞
16.2
16
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.2
16
*
8246/3-C34.1
ICD-O-3
Neuroendocrine carcinoma, NOS, of upper lobe, lung
+∞
16.2
16
*
8480/3-C34.9
ICD-O-3
Mucinous adenocarcinoma of lung, NOS
+∞
16.2
16
*
1625E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA ALIA DEF/NUD]
+∞
16.2
16
*
N06DA04
ATC
galantamine; oral
0.3
16.1
38
1106
H25.8
ICD-10 Finland
Other senile cataract
0.7
16.1
499
6580
M10.9
ICD-10 Finland
Gout, unspecified
0.6
16.0
227
3531
N04BD01
ATC
selegiline; oral
0.1
16.0
10
616
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
3.5
15.8
73
192
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.8
15.8
1106
12879
K80
ICPC
Cardiac arrhythmia NOS
0.5
15.8
141
2480
M01AC06
ATC
meloxicam; systemic, rectal
0.8
15.8
1381
15634
L02BB03
ATC
bicalutamide; oral
0.5
15.7
126
2289
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
21.4
15.7
23
10
S82
ICPC
Naevus/mole
0.6
15.7
266
3966
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.7
15.7
422
5710
L90
ICPC
Osteoarthrosis of knee
0.5
15.7
106
2032
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.0
15.7
200
935
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
0.5
15.5
114
2129
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.8
15.5
1240
14201
RS221
NOMESCO Finland
NA
2.8
15.5
99
326
114
Kela drug reimbursment
Glaucoma
0.7
15.4
366
5077
SGA01
NOMESCO Finland
Tooth opening as first aid
0.6
15.4
226
3484
D06BB10
ATC
imiquimod; topical
0.4
15.4
71
1553
J96.1
ICD-10 Finland
Chronic respiratory failure
1.9
15.4
227
1123
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
0.6
15.4
265
3931
I49.3
ICD-10 Finland
Ventricular premature depolarization
0.5
15.3
140
2449
J01CE02
ATC
phenoxymethylpenicillin; oral
0.8
15.3
3072
31890
H02AB07
ATC
prednisone; oral
1.4
15.2
963
6788
C34.04
ICD-10 Finland
Malignant tumor of the main bronchial macrocellular anaplastic carcinoma
55.7
15.2
18
*
C34.03
ICD-10 Finland
Malignant tumor of the main bronchial bronchoalveolar carcinoma
+∞
15.2
15
*
363
Kela drug reimbursment
Crizotinib
+∞
15.2
15
*
1628B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA MICROCELLURE]
+∞
15.2
15
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
0.7
15.1
506
6583
SPAT1148
SPAT
Treatment of chronic ulcer or burn
0.7
15.0
545
6997
WX402
NOMESCO Finland
General anaesthesia
1.4
15.0
722
4852
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.3
14.9
30
939
U07
ICPC
Urine symptom/complaint other
0.5
14.9
111
2065
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
0.5
14.8
136
2372
N02AC04
ATC
dextropropoxyphene; oral
1.6
14.8
363
2102
DFF15
NOMESCO Finland
Speech audiometry
0.5
14.6
101
1919
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
14.6
1514
16831
SPAT1211
SPAT
Application of soft bandage
0.6
14.6
237
3563
R03BB02
ATC
oxitropium bromide; inhalant
2.5
14.5
110
403
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.5
14.5
115
2096
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
8.7
14.5
31
33
WX290
NOMESCO Finland
Other blockade of nerve
0.8
14.5
1107
12763
N17
ICPC
Vertigo/dizziness
0.6
14.5
307
4359
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
0.5
14.5
124
2205
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
0.6
14.4
234
3523
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
0.4
14.3
64
1421
D01AE16
ATC
amorolfine; topical
0.7
14.3
355
4879
WE198
NOMESCO Finland
Palliative cystotatic therapy
12.9
14.3
25
18
Y77
ICPC
Malignant neoplasm prostate
0.5
14.2
88
1735
KED22
NOMESCO Finland
Transurethral resection of prostate
0.7
14.2
356
4886
8012/3-C34.1
ICD-O-3
Large cell carcinoma, NOS, of upper lobe, lung
+∞
14.2
14
*
8000/3-C34.2
ICD-O-3
Neoplasm, malignant of middle lobe, lung
+∞
14.2
14
*
8480/3-C34.1
ICD-O-3
Mucinous adenocarcinoma of upper lobe, lung
+∞
14.2
14
*
1622X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,EI HIST/SYTOL DG]
+∞
14.2
14
*
8240/3-C34.2
ICD-O-3
Neuroendocrine tumor, NOS, of middle lobe, lung
+∞
14.2
14
*
M70.6
ICD-10 Finland
Trochanteric bursitis
0.6
14.1
258
3783
WF099
NOMESCO Finland
Other radiotherapy
4.2
14.1
54
121
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
0.6
14.1
212
3248
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.8
14.1
250
1317
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
3.8
14.1
59
144
ZXC50
NOMESCO Finland
Cryotherapy
0.4
14.0
56
1294
L01EB01
ATC
gefitinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
139.1
14.0
15
*
S02.51
ICD-10 Finland
Fracture of tooth, open
0.6
14.0
158
2601
1440
FHL
Mediastinoscopy
10.4
14.0
27
24
SPAT1101
SPAT
Orthostatic test
0.5
14.0
124
2182
R00.1
ICD-10 Finland
Bradycardia, unspecified
0.5
13.9
84
1668
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.6
13.8
170
2736
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.7
13.8
666
8177
L12
ICPC
Hand/finger symptom/complaint
0.7
13.8
322
4480
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.7
13.8
374
5057
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
4.2
13.7
51
112
WZA90
NOMESCO Finland
Other doctors statement
0.7
13.6
607
7548
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
0.6
13.6
217
3282
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.1
13.6
162
739
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
2.7
13.6
92
316
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.6
13.5
293
4140
B35.1
ICD-10 Finland
Tinea unguium
0.5
13.5
90
1734
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
0.5
13.4
93
1764
L28
ICPC
Limited function/disability (L)
0.7
13.4
694
8434
L02AE02
ATC
leuprorelin; implant, parenteral
0.6
13.3
216
3253
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
0.7
13.3
502
6410
C39.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs
27.8
13.3
18
6
AN1
HP
Coronary angiography
0.7
13.3
589
7330
S12
ICPC
Insect bite/sting
0.6
13.3
165
2651
A10BK03
ATC
empagliflozin; oral
0.5
13.3
126
2174
C09DA01
ATC
losartan and diuretics; oral
0.7
13.3
322
4448
N05AD01
ATC
haloperidol; systemic
1.7
13.2
264
1443
K04.5
ICD-10 Finland
Chronic apical periodontitis
0.7
13.2
772
9228
-44
ICPC
Preventive immunization/medic
0.6
13.2
253
3670
R4110
SPAT
NA
0.3
13.2
23
774
L01CE01
ATC
topotecan; systemic
+∞
13.1
13
*
8013/3-C34.1
ICD-O-3
Large cell neuroendocrine carcinoma of upper lobe, lung
+∞
13.1
13
*
8249/3-C34.3
ICD-O-3
Neuroendocrine tumor, grade 2 of lower lobe, lung
+∞
13.1
13
*
1623D
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MACROCELLUL]
+∞
13.1
13
*
1624B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA MICROCELLURE]
+∞
13.1
13
*
1624A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA EPIDERMOIDES]
+∞
13.1
13
*
1623F
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,MUU HISTOLOGIA]
+∞
13.1
13
*
H29
ICPC
Ear symptom/complaint other
0.6
13.1
268
3833
C34.93
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary bronchoalveolar carcinoma
69.7
13.1
15
*
E0000UV
ATC
NA
0.8
13.1
1558
17109
N05BA06
ATC
lorazepam; systemic, sublingual
1.6
13.1
353
2094
C05AA08
ATC
fluocortolone; rectal, topical
0.7
13.1
438
5705
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
0.6
13.1
301
4203
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.6
13.1
197
3018
J01CA08
ATC
pivmecillinam; oral
0.8
13.1
1040
11946
M02AA10
ATC
ketoprofen; topical
0.7
13.1
527
6651
C34.94
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary macrocellular anaplastic carcinoma
129.8
13.0
14
*
Z00.8
ICD-10 Finland
Other general examinations
0.5
13.0
126
2163
R52.0
ICD-10 Finland
Acute pain
2.1
13.0
149
671
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
7.9
12.9
29
34
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
0.3
12.9
38
998
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
3.2
12.9
68
200
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
0.4
12.9
43
1068
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
0.4
12.9
58
1278
SPAT1100
SPAT
Long-term monitoring of blood pressure
0.6
12.9
237
3465
R01AD09
ATC
mometasone; nasal
0.8
12.8
1453
16037
N03AX14
ATC
levetiracetam; systemic
2.1
12.8
145
649
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.3
12.8
20
711
4040
NOMESCO Finland
NA
19.6
12.8
19
9
R5140
NOMESCO Finland
Monitoring the use of the aid
0.6
12.7
276
3900
SPAT1262
SPAT
Handing over of treatment supplies
0.8
12.7
748
8935
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.3
12.7
855
6078
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
0.7
12.7
303
4199
EBA00
NOMESCO Finland
Extraction of tooth
0.8
12.6
1127
12777
A10BK01
ATC
dapagliflozin; oral
0.4
12.6
52
1185
J43.2
ICD-10 Finland
Centrilobular emphysema
4.8
12.6
41
79
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
0.5
12.5
92
1716
A29
ICPC
General symptom/complaint other
0.7
12.5
355
4764
SPAT1222
SPAT
Counselling/guidance promoting independent living
0.7
12.5
638
7778
R24
ICPC
Haemoptysis
3.6
12.5
55
141
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
0.7
12.4
553
6879
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
46.4
12.4
15
*
TXQ05
NOMESCO Finland
Puncture of skin, site unspecified
46.4
12.4
15
*
GA3CT
NOMESCO Finland
Pleural cytology with CT guidance
46.4
12.4
15
*
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.7
12.4
453
5812
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
0.6
12.4
266
3762
L01
ICPC
Neck symptom/complaint
0.7
12.3
291
4042
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
0.6
12.3
154
2468
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
0.4
12.3
44
1060
S01EE01
ATC
latanoprost; ophthalmic
0.6
12.2
215
3177
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
0.7
12.2
333
4500
H91.9
ICD-10 Finland
Hearing loss, unspecified
0.5
12.2
91
1687
N02AA03
ATC
hydromorphone; systemic, rectal
5.4
12.2
36
62
8249/3-C34.1
ICD-O-3
Neuroendocrine tumor, grade 2 of upper lobe, lung
+∞
12.1
12
*
8550/3-C34.1
ICD-O-3
Acinar cell carcinoma of upper lobe, lung
+∞
12.1
12
*
1629B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA MICROCELLURE]
+∞
12.1
12
*
8140/3-C34.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of lung
+∞
12.1
12
*
C08CA02
ATC
felodipine; oral
0.7
12.1
420
5438
Z71.8
ICD-10 Finland
Other specified counselling
0.7
12.1
671
8084
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
0.6
12.1
211
3122
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
1.9
12.1
170
830
S22
ICPC
Nail symptom/complaint
0.5
12.0
117
2002
S15
ICPC
Foreign body in skin
0.5
12.0
124
2090
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
0.6
11.9
135
2223
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
0.6
11.9
249
3542
I49.5
ICD-10 Finland
Sick sinus syndrome
0.5
11.8
118
2006
N87
ICPC
Parkinsonism
0.2
11.8
11
525
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
0.4
11.8
37
943
N04BC05
ATC
pramipexole; oral
0.6
11.8
188
2837
K04.1
ICD-10 Finland
Necrosis of pulp
0.6
11.7
171
2638
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
0.5
11.7
72
1421
K02.0
ICD-10 Finland
Caries limited to enamel
0.6
11.6
159
2491
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
0.7
11.6
460
5829
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
0.7
11.6
385
5022
U02
ICPC
Urinary frequency/urgency
0.7
11.6
310
4202
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
5.6
11.5
33
55
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
0.6
11.5
202
2984
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.9
11.5
46
109
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
0.7
11.4
334
4456
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
11.4
1429
11019
M02AA07
ATC
piroxicam; topical
0.8
11.4
1746
18742
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
0.4
11.4
59
1238
I35.0
ICD-10 Finland
Aortic (valve) stenosis
0.7
11.4
260
3634
R53
ICD-10 Finland
Malaise and fatigue
0.8
11.4
858
9935
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
12.4
11.4
20
15
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.2
11.3
110
463
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
0.7
11.2
438
5565
GBA35
NOMESCO Finland
Endoscopic insertion of stent into trachea
60.2
11.2
13
*
C07AB02
ATC
metoprolol; systemic
0.8
11.2
1312
14464
S21
ICPC
Skin texture symptom/complaint
0.7
11.1
370
4828
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
11.1
976
7200
1622B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA MICROCELLURE]
+∞
11.1
11
*
8230/3-C34.1
ICD-O-3
Solid carcinoma, NOS, of upper lobe, lung
+∞
11.1
11
*
XCK00
NOMESCO Finland
Perimetry
0.6
11.1
197
2906
R03BA02
ATC
budesonide; inhalant
1.3
11.1
909
6647
GCA08
NOMESCO Finland
Bronchoscopic excsion of lesion of bronchus
17.5
11.1
17
9
C34.07
ICD-10 Finland
Malignant tumor of the main bronchus carcinoid
111.3
11.1
12
*
1XC18
NOMESCO Finland
NA
111.3
11.1
12
*
R01AD08
ATC
fluticasone; nasal
0.8
11.1
850
9821
N39.4
ICD-10 Finland
Other specified urinary incontinence
0.6
11.0
183
2739
N30.0
ICD-10 Finland
Acute cystitis
0.7
11.0
374
4860
A07AA02
ATC
nystatin; oral
1.5
11.0
377
2370
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
0.5
11.0
71
1374
F05.1
ICD-10 Finland
Delirium superimposed on dementia
0.1
11.0
*
311
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
0.6
10.9
142
2249
K77
ICPC
Heart failure
0.4
10.9
38
928
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
2.0
10.9
129
590
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
6.3
10.9
28
41
U05
ICPC
Urination problems other
0.5
10.9
117
1946
OAA67
SPAT
NA
0.3
10.8
20
650
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
0.6
10.8
144
2272
I20.09
ICD-10 Finland
Unstable angina
0.6
10.8
239
3364
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
1.7
10.7
204
1102
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
0.6
10.7
167
2534
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
0.7
10.7
293
3954
I44.1
ICD-10 Finland
Atrioventricular block, second degree
0.4
10.7
51
1101
C09CA03
ATC
valsartan; oral
0.7
10.7
285
3868
Y06
ICPC
Prostate symptom/complaint
0.5
10.7
72
1375
J98.4
ICD-10 Finland
Other disorders of lung
6.2
10.7
28
42
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
8.2
10.6
23
26
M04AA01
ATC
allopurinol; systemic
0.8
10.6
756
8818
SPAT1377
SPAT
Polysomnography
0.3
10.5
27
749
N07BC02
ATC
methadone; systemic
6.0
10.5
28
43
J02AC02
ATC
itraconazole; systemic
0.7
10.5
516
6326
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
4.9
10.5
33
62
G04BD08
ATC
solifenacin; oral
0.6
10.5
200
2899
XCW99
NOMESCO Finland
Other investigative procedure of eye
0.7
10.5
383
4917
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
12.8
10.4
18
13
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
6.3
10.4
27
40
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
0.1
10.4
6
390
N05BA04
ATC
oxazepam; oral
1.2
10.3
1400
10881
R05FB02
ATC
cough suppressants and expectorants
1.2
10.3
2426
19895
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
0.5
10.3
106
1787
XF404
NOMESCO Finland
Ambulatory ECG
0.7
10.3
307
4080
GEB40
NOMESCO Finland
Mediastinotomy and extended excision of lesion
55.6
10.3
12
*
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
3.5
10.3
46
121
OAB43
SPAT
NA
0.5
10.2
60
1201
SGC00
NOMESCO Finland
Local medication of root channels of tooth
0.6
10.2
163
2459
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
0.3
10.2
16
566
R83
ICPC
Respiratory infection other
0.7
10.2
352
4564
H25.0
ICD-10 Finland
Senile incipient cataract
0.6
10.2
210
2994
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.0
10.1
121
557
8013/3-C34.3
ICD-O-3
Large cell neuroendocrine carcinoma of lower lobe, lung
+∞
10.1
10
*
1628C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,ADENOCARCINOMA]
+∞
10.1
10
*
9591/3-C34.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lung, NOS
+∞
10.1
10
*
8020/3-C34.3
ICD-O-3
Carcinoma, undifferentiated, NOS, of lower lobe, lung
+∞
10.1
10
*
1625F
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,MUU HISTOLOGIA]
+∞
10.1
10
*
8020/3-C34.1
ICD-O-3
Carcinoma, undifferentiated, NOS, of upper lobe, lung
+∞
10.1
10
*
8560/3-C34.3
ICD-O-3
Adenosquamous carcinoma of lower lobe, lung
+∞
10.1
10
*
8560/3-C34.1
ICD-O-3
Adenosquamous carcinoma of upper lobe, lung
+∞
10.1
10
*
1625G
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,VAIN SYTOL DG]
+∞
10.1
10
*
8070/3-C34.8
ICD-O-3
Squamous cell carcinoma, NOS, of overlapping lesion of lung
+∞
10.1
10
*
R25.1
ICD-10 Finland
Tremor, unspecified
0.4
10.1
40
923
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
0.6
10.1
224
3145
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
3.1
10.0
53
158
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
4.5
9.9
34
70
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.5
9.9
45
120
S01EE05
ATC
tafluprost; ophthalmic
0.5
9.9
59
1176
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
0.6
9.8
127
2017
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
9.8
345
4460
UDC00
NOMESCO Finland
Ear microscopy
0.6
9.8
179
2620
R07.4
ICD-10 Finland
Chest pain, unspecified
0.8
9.8
1192
13106
P06
ICPC
Sleep disturbance
0.6
9.8
167
2481
J01EA01
ATC
trimethoprim; systemic
0.8
9.7
991
11105
F06.7
ICD-10 Finland
Mild cognitive disorder
0.5
9.7
57
1140
A02BC02
ATC
pantoprazole; systemic
1.2
9.7
4062
34871
ZXH06
SPAT
NA
0.3
9.7
18
584
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
0.4
9.7
50
1046
JN5AP
NOMESCO Finland
Total body PET (1 picture)
12.1
9.7
17
13
ZXA10
NOMESCO Finland
Bilateral
0.8
9.6
781
8978
S06.0
ICD-10 Finland
Concussion
0.7
9.6
280
3737
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
5.0
9.6
30
56
H84
ICPC
Presbyacusis
0.5
9.6
93
1592
Y85
ICPC
Benign prostatic hypertrophy
0.3
9.6
27
719
Z57.2
ICD-10 Finland
Occupational exposure to dust
3.7
9.6
41
104
SPAT1058
SPAT
PEF monitoring instruction
0.6
9.6
200
2845
A02BX02
ATC
sucralfate; oral
1.5
9.5
311
1934
TKE00
NOMESCO Finland
Needle biopsy of prostate
0.7
9.5
228
3156
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.8
9.5
619
7307
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.2
9.5
92
387
K76
ICPC
Ischaemic heart dis without angina
0.5
9.5
56
1118
H03AA01
ATC
levothyroxine sodium; systemic
0.8
9.5
738
8523
W19
ICD-10 Finland
Unspecified fall
0.7
9.5
291
3847
D01AE15
ATC
terbinafine; topical
0.7
9.5
216
3018
XX9XW
NOMESCO Finland
NA
3.3
9.4
45
125
R92
ICPC
Neoplasm respiratory unspecified
24.1
9.4
13
5
L14
ICPC
Leg/thigh symptom/complaint
0.6
9.4
178
2584
I50
ICD-10 Finland
Heart failure
0.6
9.4
101
1679
TDA90
SPAT
NA
0.3
9.4
25
680
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
0.7
9.4
322
4177
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
5.2
9.4
28
50
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
0.6
9.4
120
1908
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
0.5
9.4
63
1205
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
2.0
9.3
119
562
1628X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,EI HIST/SYTOL DG]
51.0
9.3
11
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.0
9.3
112
517
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
5.6
9.3
26
43
UGB02
NOMESCO Finland
Tracheoscopy
5.6
9.3
26
43
K05.1
ICD-10 Finland
Chronic gingivitis
0.5
9.3
93
1575
A10BH01
ATC
sitagliptin; oral
0.7
9.2
337
4324
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.8
9.2
788
9004
AXX01
SPAT
NA
0.2
9.2
9
415
S01.0
ICD-10 Finland
Open wound of scalp
0.7
9.2
244
3308
1243
FHL
Bronchoscopy and other therapeutic procedure
5.8
9.2
25
40
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
0.7
9.2
351
4470
SPAT1229
SPAT
Assessment of need for aid
0.7
9.2
300
3921
N19
ICD-10 Finland
Unspecified kidney failure
0.6
9.2
111
1789
L16
ICPC
Ankle symptom/complaint
0.6
9.1
202
2838
U04
ICPC
Incontinence urine
0.6
9.1
108
1753
D07AC01
ATC
betamethasone; topical
0.8
9.1
1511
16160
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
0.3
9.1
16
531
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
0.5
9.1
71
1297
8550/3-C34.3
ICD-O-3
Acinar cell carcinoma of lower lobe, lung
+∞
9.1
9
*
8072/3-C34.3
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of lower lobe, lung
+∞
9.1
9
*
1629C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,ADENOCARCINOMA]
+∞
9.1
9
*
1242
FHL
Bronchoscopy and transbronchial lung apia
6.8
9.1
22
30
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.2
9.1
46
134
N30.9
ICD-10 Finland
Cystitis, unspecified
0.6
9.1
121
1902
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
2.7
9.0
58
197
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
0.7
9.0
275
3639
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
0.6
9.0
101
1662
M01AB05
ATC
diclofenac; systemic, rectal
0.9
9.0
3153
31794
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
9.0
949
7159
S27.0
ICD-10 Finland
Traumatic pneumothorax
2.7
9.0
58
198
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.2
9.0
88
371
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.9
9.0
133
666
A02BC01
ATC
omeprazole; systemic
1.2
9.0
1823
14723
H43.8
ICD-10 Finland
Other disorders of vitreous body
0.7
9.0
208
2894
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
0.4
9.0
31
757
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
0.2
8.9
10
427
N05AH04
ATC
quetiapine; oral
0.7
8.9
426
5251
SPAT1360
SPAT
Extensive global examination
0.7
8.9
225
3083
D07AB02
ATC
hydrocortisone butyrate; topical
0.8
8.9
1119
12284
M79.1
ICD-10 Finland
Myalgia
0.7
8.9
267
3547
I20.01
ICD-10 Finland
Unstable angina
0.6
8.9
103
1678
R03AC18
ATC
indacaterol; inhalant
2.4
8.9
74
289
R55
ICD-10 Finland
Syncope and collapse
0.7
8.9
476
5771
M76.6
ICD-10 Finland
Achilles tendinitis
0.5
8.9
61
1158
R41.3
ICD-10 Finland
Other amnesia
0.5
8.9
67
1233
J98.1
ICD-10 Finland
Pulmonary collapse
2.7
8.9
57
194
M48.0
ICD-10 Finland
Spinal stenosis
0.8
8.9
505
6072
EBA05
NOMESCO Finland
Complicated extraction of tooth
0.8
8.8
516
6182
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
2.8
8.8
56
188
WYA20
NOMESCO Finland
Home visit
0.4
8.8
29
723
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.5
8.8
92
1543
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
1.8
8.8
152
798
K03.00
ICD-10 Finland
Approximal wear
0.5
8.8
55
1075
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
5.2
8.8
26
46
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
0.5
8.8
71
1281
A69.2
ICD-10 Finland
Lyme disease
0.5
8.8
79
1380
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1.8
8.8
148
770
J01DA06
ATC
[U] cefuroxime; systemic
1.3
8.8
747
5483
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
0.6
8.8
154
2270
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
8.8
355
2315
A10BH05
ATC
linagliptin; oral
0.6
8.7
153
2256
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
0.6
8.7
160
2338
GWW96
NOMESCO Finland
Other reoperation in thoracic surgery
12.6
8.7
15
11
XG466
NOMESCO Finland
Sleep oxymetry
1.7
8.7
188
1055
R81
ICPC
Pneumonia
1.6
8.7
198
1129
M09AX01
ATC
hyaluronic acid; parenteral
0.6
8.7
152
2245
A44
ICPC
General and Unspecified, Preventive immunization/medic
0.6
8.7
182
2583
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.6
8.7
61
220
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
0.6
8.6
141
2112
I48.1
ICD-10 Finland
Persistent atrial fibrillation
0.5
8.6
51
1016
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
3.0
8.6
47
145
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
0.6
8.6
179
2547
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
0.6
8.6
177
2522
N81.6
ICD-10 Finland
Rectocele
0.5
8.6
78
1358
ACC51
NOMESCO Finland
Release of median nerve
0.6
8.6
133
2017
A46
ICD-10 Finland
Erysipelas
0.8
8.6
622
7247
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
3.1
8.6
44
130
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
2.3
8.6
78
321
KGH10
NOMESCO Finland
Operation for phimosis
0.5
8.5
52
1023
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
0.5
8.5
48
974
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
8.3
8.5
18
20
I50.1
ICD-10 Finland
Left ventricular failure
0.7
8.5
236
3171
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
0.5
8.5
49
982
N81.1
ICD-10 Finland
Cystocele
0.5
8.5
87
1465
TPH07
NOMESCO Finland
Cathetrisation of artery
1.3
8.4
635
4588
W00
ICD-10 Finland
Fall on same level involving ice and snow
0.7
8.4
286
3714
S01EC04
ATC
brinzolamide; ophthalmic
0.6
8.4
97
1581
GDA20
NOMESCO Finland
Excision of lesion of lung
6.0
8.4
22
34
I25
ICD-10 Finland
Chronic ischaemic heart disease
0.7
8.3
186
2607
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
0.6
8.3
142
2108
A28
ICPC
Limited function/disability NOS
0.8
8.3
837
9404
ZXC15
NOMESCO Finland
Use of photodynamic technique
0.3
8.3
20
568
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
0.7
8.3
241
3214
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
0.6
8.3
141
2091
CKC12
NOMESCO Finland
Photocoagulation of retina
0.5
8.3
72
1268
R06.5
ICD-10 Finland
Mouth breathing
0.7
8.3
186
2601
C02AC05
ATC
moxonidine; oral
0.6
8.3
118
1822
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.8
8.2
734
8353
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
4.2
8.2
30
67
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
0.8
8.2
528
6246
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.8
8.2
629
7278
163
Kela drug reimbursment
Abiraterone and enzalutamide
0.3
8.1
13
456
D38
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
83.5
8.1
9
*
8070/2-C34.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of lung, NOS
83.5
8.1
9
*
WX111
NOMESCO Finland
Local infiltration anesthesia
0.4
8.1
40
849
S04
ICPC
Lump/swelling localized
0.7
8.1
211
2873
L01ED01
ATC
crizotinib; oral
+∞
8.1
8
*
8071/3-C34.1
ICD-O-3
Squamous cell carcinoma, keratinizing, NOS, of upper lobe, lung
+∞
8.1
8
*
8260/3-C34.1
ICD-O-3
Papillary adenocarcinoma, NOS, of upper lobe, lung
+∞
8.1
8
*
8012/3-C34.9
ICD-O-3
Large cell carcinoma, NOS, of lung, NOS
+∞
8.1
8
*
8260/3-C34.3
ICD-O-3
Papillary adenocarcinoma, NOS, of lower lobe, lung
+∞
8.1
8
*
R03BA01
ATC
beclometasone; inhalant
1.3
8.1
783
5848
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
0.7
8.0
277
3586
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
0.5
8.0
73
1269
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
0.6
8.0
129
1937
Z25.1
ICD-10 Finland
Need for immunization against influenza
0.6
8.0
110
1714
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
0.4
8.0
28
676
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
0.4
8.0
26
648
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.1
8.0
84
369
M05BA02
ATC
clodronic acid; systemic
2.8
8.0
49
164
S09
ICPC
Infected finger/toe
0.4
8.0
42
869
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
4.3
7.9
28
61
G30
ICD-10 Finland
Alzheimer disease
0.3
7.9
21
572
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
0.7
7.9
212
2865
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
4.0
7.9
30
70
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
0.7
7.9
374
4607
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.6
7.9
107
1671
I34.1
ICD-10 Finland
Mitral (valve) prolapse
0.5
7.9
47
932
B01AC04
ATC
clopidogrel; oral
0.8
7.8
910
10074
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
5.2
7.8
23
41
JN4DD
NOMESCO Finland
Scout CT scan of torso
5.2
7.8
23
41
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
0.5
7.8
49
956
C79
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified sites
30.9
7.8
10
*
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.6
7.8
147
2129
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.2
7.8
1017
7861
S06
ICPC
Rash localized
0.6
7.7
114
1747
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
0.6
7.7
160
2279
A10BJ06
ATC
semaglutide; parenteral
0.4
7.7
26
639
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
0.8
7.7
629
7236
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
0.3
7.7
13
442
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.2
7.7
932
7140
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.5
7.7
60
227
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
0.6
7.7
137
2015
K22
ICPC
Risk factor cardiovascular disease
0.6
7.7
140
2046
C43.12
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type
20.4
7.7
11
5
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
4.8
7.7
24
46
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
0.5
7.7
52
991
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.6
7.7
192
1125
F17.22
ICD-10 Finland
Addiction-related addiction currently uses controlled substitution treatment
7.0
7.7
18
24
M54.4
ICD-10 Finland
Lumbago with sciatica
0.7
7.6
407
4939
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
0.6
7.6
139
2030
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
0.6
7.6
85
1399
WZC30
SPAT
NA
0.3
7.6
15
473
A02BA04
ATC
nizatidine; systemic
1.3
7.6
552
3967
N04BC04
ATC
ropinirole; oral
0.2
7.6
6
317
K03.66
ICD-10 Finland
Tooth plaque
0.6
7.6
114
1737
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
2.5
7.6
56
207
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.6
7.6
165
934
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
4.1
7.5
28
64
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
5.0
7.5
23
43
J30.0
ICD-10 Finland
Vasomotor rhinitis
0.4
7.5
31
701
WZC00
SPAT
NA
0.5
7.5
47
919
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.5
7.5
256
1611
XF402
NOMESCO Finland
ECG with work load test
0.8
7.5
421
5072
SPAT1285
SPAT
Provision of consultation response
0.6
7.5
122
1828
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
3.3
7.5
36
102
L11
ICPC
Wrist symptom/complaint
0.6
7.5
129
1908
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
2.6
7.5
50
176
81
HP
Angiography of the heart and coronary arteries
0.8
7.5
406
4915
SPAT1252
SPAT
Overall medication plan or its review
0.7
7.5
248
3231
RS220
NOMESCO Finland
NA
2.3
7.5
65
262
N05CD07
ATC
temazepam; oral
1.2
7.5
994
7692
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.7
7.5
215
2873
G04BD09
ATC
trospium; oral
0.5
7.5
44
877
L01EB02
ATC
erlotinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
41.7
7.4
9
*
H3600, E113
ICD-10 Finland
NA
0.3
7.4
18
511
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
0.6
7.4
134
1961
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.5
7.4
275
1763
K05
ICPC
Irregular heartbeat other
0.5
7.4
56
1028
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.5
7.4
67
1167
M15
ICD-10 Finland
Polyarthrosis
0.6
7.4
94
1495
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
0.4
7.4
23
583
R4135
NOMESCO Finland
Rehabilitation for hearing problems
0.4
7.4
36
767
U06
ICPC
Haematuria
0.5
7.4
52
976
C03AA03
ATC
hydrochlorothiazide; oral
0.8
7.4
421
5056
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
0.4
7.4
35
753
1CD02
NOMESCO Finland
NA
3.0
7.3
40
125
N18.0
ICD-10 Finland
End-stage renal disease
0.3
7.3
18
507
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.0
7.3
90
422
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
0.5
7.3
41
826
I44.2
ICD-10 Finland
Atrioventricular block, complete
0.6
7.3
93
1473
M10.0
ICD-10 Finland
Idiopathic gout
0.6
7.3
93
1475
OAB44
SPAT
NA
0.4
7.2
26
624
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
0.4
7.2
26
624
SPAT1324
SPAT
Screening procedure
0.6
7.2
147
2096
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
0.5
7.2
57
1035
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.4
7.2
57
219
R01AD01
ATC
beclometasone; nasal
0.8
7.2
421
5045
L30.9
ICD-10 Finland
Dermatitis, unspecified
0.8
7.2
554
6416
L29
ICPC
Musculoskeletal sympt/complt other
0.7
7.2
180
2466
S08
ICPC
Skin colour change
0.6
7.2
109
1660
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
0.6
7.2
89
1424
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
0.6
7.2
93
1470
AS4
HP
Physiological pacemaker insertion DDD (R)
0.4
7.2
31
691
S01GX01
ATC
cromoglicic acid; ophthalmic
0.8
7.2
402
4842
5821
FHL
Needle biopsy in the operating room
74.2
7.2
8
*
16212
ICD-8 Finland
Malignant neoplasm of trachea, bronchus and lung, Lobi superioris pulmonis
74.2
7.2
8
*
R74
ICPC
Upper respiratory infection acute
0.8
7.2
549
6360
XF640
NOMESCO Finland
NA
0.5
7.2
73
1230
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
0.6
7.1
124
1828
D06BX02
ATC
ingenol mebutate; topical
0.3
7.1
20
533
UJC01
NOMESCO Finland
Scopy of lower throat
2.3
7.1
65
268
GAC46
NOMESCO Finland
Partial decortication of pleura
4.9
7.1
22
42
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
3.0
7.1
38
117
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
0.7
7.1
201
2690
I95.1
ICD-10 Finland
Orthostatic hypotension
0.6
7.1
125
1838
P17
ICPC
Tobacco abuse
2.4
7.1
56
215
1629E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA ALIA DEF/NUD]
+∞
7.1
7
*
C79.49
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified parts of nervous system
+∞
7.1
7
*
3017
Kela drug reimbursment
Brigatinib
+∞
7.1
7
*
8046/3-C34.0
ICD-O-3
Non-small cell carcinoma of main bronchus
+∞
7.1
7
*
1629G
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,VAIN SYTOL DG]
+∞
7.1
7
*
8022/3-C34.3
ICD-O-3
Pleomorphic carcinoma of lower lobe, lung
+∞
7.1
7
*
1628E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA ALIA DEF/NUD]
+∞
7.1
7
*
8012/3-C34.3
ICD-O-3
Large cell carcinoma, NOS, of lower lobe, lung
+∞
7.1
7
*
8230/3-C34.3
ICD-O-3
Solid carcinoma, NOS, of lower lobe, lung
+∞
7.1
7
*
8010/3-C34.2
ICD-O-3
Carcinoma, NOS, of middle lobe, lung
+∞
7.1
7
*
8072/3-C34.1
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of upper lobe, lung
+∞
7.1
7
*
GCA40
NOMESCO Finland
Closure of bronchopleural fistula
+∞
7.1
7
*
C34.24
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung macrocellular anaplastic carcinoma
+∞
7.1
7
*
8000/3-C34.8
ICD-O-3
Neoplasm, malignant of overlapping lesion of lung
+∞
7.1
7
*
SPAT1079
SPAT
Echocardiography
0.2
7.1
10
370
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.4
7.1
307
2034
E83.50
ICD-10 Finland
Hypercalcemia
2.1
7.1
73
321
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
0.5
7.0
48
910
KED52
NOMESCO Finland
Visual laser resection of prostate
0.4
7.0
28
642
G03AC03
ATC
levonorgestrel; systemic
0.6
7.0
109
1648
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
0.7
7.0
184
2500
J05AB11
ATC
valaciclovir; oral
0.7
7.0
363
4421
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
0.5
7.0
43
841
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
0.6
7.0
76
1257
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
0.8
7.0
743
8306
XQ848
NOMESCO Finland
Dermatological photography
0.5
7.0
43
844
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
0.7
7.0
336
4134
J01DA01
ATC
[U] cefalexin; systemic
1.1
7.0
3906
33875
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
0.5
7.0
42
827
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
0.6
6.9
103
1574
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.4
6.9
53
202
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
0.4
6.9
29
652
J05AB01
ATC
aciclovir; systemic
0.8
6.9
690
7762
K08.80
ICD-10 Finland
Toothache NOS
0.6
6.9
95
1480
R01BA52
ATC
pseudoephedrine, combinations; oral
0.8
6.9
983
10683
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
0.7
6.9
315
3903
TQW40
SPAT
NA
0.5
6.9
39
787
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
2.1
6.9
69
299
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
27.8
6.9
9
*
K05.30
ICD-10 Finland
Periodontitis complex
0.7
6.9
346
4228
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.0
6.9
80
367
L03.0
ICD-10 Finland
Cellulitis of finger and toe
0.7
6.9
150
2106
S97
ICPC
Chronic ulcer skin
0.7
6.9
183
2475
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
0.6
6.9
140
1995
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
0.5
6.8
41
810
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
0.4
6.8
36
744
R5120
NOMESCO Finland
Preparation of an aid
0.5
6.8
69
1162
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
0.5
6.8
43
834
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
3.7
6.8
28
71
J94.9
ICD-10 Finland
Pleural condition, unspecified
2.5
6.8
51
191
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
4.2
6.8
24
53
F29
ICPC
Eye symptom/complaint other
0.7
6.8
183
2470
K04.0
ICD-10 Finland
Pulpitis
0.6
6.8
114
1692
M35.3
ICD-10 Finland
Polymyalgia rheumatica
0.6
6.8
119
1749
SPAT1234
SPAT
Support of social functional capacity
0.7
6.7
169
2311
R03BB07
ATC
umeclidinium bromide; inhalant
2.4
6.7
51
194
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
7.3
6.7
15
19
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
0.9
6.7
1480
15512
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
0.6
6.7
81
1302
C02EA02
ATC
NA
0.7
6.7
229
2965
F17.1
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, harmful use
8.1
6.7
14
16
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
0.4
6.6
21
526
M53.0
ICD-10 Finland
Cervicocranial syndrome
0.6
6.6
137
1946
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
0.1
6.6
*
253
U71
ICPC
Cystitis/urinary infection other
0.6
6.6
98
1498
R02
ICPC
Shortness of breath/dyspnoea
1.3
6.6
647
4835
T92
ICPC
Gout
0.5
6.6
37
749
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
0.7
6.6
258
3276
SGC10
NOMESCO Finland
Covering pulpa of tooth
0.6
6.6
105
1579
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
0.6
6.6
97
1483
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.3
6.6
57
232
K99
ICPC
Cardiovascular disease other
0.6
6.6
70
1161
K84
ICPC
Heart disease other
0.5
6.6
60
1039
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.9
6.6
1497
15659
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
0.3
6.6
16
449
C10AA04
ATC
fluvastatin; oral
0.8
6.6
415
4919
R03AC19
ATC
olodaterol; inhalant
2.8
6.6
39
129
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
0.4
6.6
34
707
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
0.8
6.6
407
4835
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
0.8
6.5
350
4241
C07AG02
ATC
carvedilol; oral
0.7
6.5
246
3136
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
0.5
6.5
51
924
SPAT1251
SPAT
Organisation of medication
0.6
6.5
112
1654
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
2.0
6.5
76
352
WX723
NOMESCO Finland
CPAP therapy
0.5
6.5
36
729
A01AB09
ATC
miconazole; local oral
1.3
6.5
473
3406
Z01.7
ICD-10 Finland
Laboratory examination
0.7
6.5
302
3729
SPAT1370
SPAT
Other health check-up
0.6
6.5
76
1227
GAC36
NOMESCO Finland
Chemical pleurodesis
10.1
6.5
12
11
GBA28
NOMESCO Finland
Endoscopic laser therapy of lesion of trachea
15.4
6.5
10
6
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
4.0
6.4
24
56
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
7.6
6.4
14
17
7863A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Haemoptysis
2.5
6.4
47
176
L19
ICPC
Muscle symptom/complaint NOS
0.4
6.4
26
591
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.0
6.4
77
360
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.3
6.4
418
2961
Z85.1
ICD-10 Finland
Personal history of malignant neoplasm of trachea, bronchus and lung
20.9
6.4
9
*
G04BE03
ATC
sildenafil; oral
0.4
6.4
19
491
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.6
6.4
72
1178
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
0.2
6.4
6
282
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
4.1
6.4
23
52
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
0.9
6.4
1412
14806
K40
ICD-10 Finland
Inguinal hernia
0.5
6.4
49
891
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.4
6.4
257
1680
L02BB04
ATC
enzalutamide; oral
0.3
6.4
10
351
SPAT1236
SPAT
Informing family of child’s disability
0.4
6.4
29
631
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
0.7
6.3
216
2799
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
2.5
6.3
46
172
R06AX27
ATC
desloratadine; oral
0.8
6.3
617
6955
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
0.4
6.3
26
587
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.7
6.3
272
3397
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
5.2
6.3
18
32
F51.0
ICD-10 Finland
Nonorganic insomnia
0.7
6.3
247
3129
N04BD02
ATC
rasagiline; oral
0.1
6.3
*
197
XF600
SPAT
NA
0.1
6.3
*
198
C38.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura
11.3
6.3
11
9
D11
ICPC
Diarrhoea
0.7
6.2
199
2607
NF1AA
SPAT
NA
0.2
6.2
6
279
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
0.6
6.2
131
1853
GDC23
NOMESCO Finland
Lobectomy and segment resection of lung
65.0
6.2
7
*
DQA10
NOMESCO Finland
Biopsy of larynx
2.6
6.2
42
151
SPAT1215
SPAT
Assessment of need for medical rehabilitation
0.6
6.2
88
1355
K03.0
ICD-10 Finland
Excessive attrition of teeth
0.4
6.2
32
663
R21
ICPC
Throat symptom/complaint
0.8
6.2
344
4145
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
2.2
6.2
59
251
R44
ICPC
Respiratory, Preventive immunization/medic
0.4
6.2
25
568
S86.0
ICD-10 Finland
Injury of Achilles tendon
0.5
6.2
36
714
H40.11
ICD-10 Finland
Low pressure glaucoma
0.5
6.2
36
714
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
0.4
6.2
24
554
X59
ICD-10 Finland
Exposure to unspecified factor
0.8
6.2
589
6657
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
5.4
6.2
17
29
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
0.6
6.2
79
1249
R03BB06
ATC
glycopyrronium bromide; inhalant
2.8
6.2
37
124
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
0.4
6.1
30
635
K29
ICPC
Cardiovascular sympt/complt other
0.6
6.1
119
1712
TFP20
NOMESCO Finland
Cardiodefibrillation
0.7
6.1
302
3702
A04
ICPC
Weakness/tiredness general
0.8
6.1
474
5484
WVA30
SPAT
NA
0.5
6.1
34
689
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
0.6
6.1
108
1582
J37.0
ICD-10 Finland
Chronic laryngitis
1.6
6.1
145
842
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
2.9
6.1
35
112
D01
ICPC
Abdominal pain/cramps general
0.7
6.1
216
2780
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
0.1
6.1
*
196
V03AA01
ATC
NA
1.9
6.1
87
435
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
0.8
6.1
371
4418
XX1XW
NOMESCO Finland
Extensive written report from radiologist
1.7
6.1
111
599
U29
ICPC
Urinary symptom/complaint other
0.5
6.1
52
917
8022/3-C34.1
ICD-O-3
Pleomorphic carcinoma of upper lobe, lung
+∞
6.1
6
*
1624G
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,VAIN SYTOL DG]
+∞
6.1
6
*
8551/3-C34.9
ICD-O-3
Acinar cell cystadenocarcinoma of lung, NOS
+∞
6.1
6
*
1625D
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MACROCELLUL]
+∞
6.1
6
*
3026
Kela drug reimbursment
Lorlatinib
+∞
6.1
6
*
1629F
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,MUU HISTOLOGIA]
+∞
6.1
6
*
8246/3-C34.3
ICD-O-3
Neuroendocrine carcinoma, NOS, of lower lobe, lung
+∞
6.1
6
*
I48.2
ICD-10 Finland
Chronic atrial fibrillation
0.5
6.1
59
1002
R03AC03
ATC
terbutaline; inhalant
1.2
6.0
647
4889
C01DA14
ATC
isosorbide mononitrate; oral
0.9
6.0
1266
13335
N30
ICD-10 Finland
Cystitis
0.7
6.0
128
1804
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.5
6.0
53
928
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
0.7
6.0
204
2643
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
5.3
6.0
17
30
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3750
51598
0.42
320.78
4.8
5.2
mmol/l
6.2
6.1
2.17
3216
45462
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3324
48292
0.41
307.65
3.4
4.3
mmol/l
1.3
1.3
5.42
2786
42547
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
271
10
261.97
307.65
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1058
2460
4.46
307.65
2.2
2.7
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
1063
755
14.95
307.65
2.3
1.7
ug/l
31.6
19.8
4.53
1047
736
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3630
52000
0.39
307.65
4.1
5.4
mmol/l
2.6
2.5
2.71
3058
46437
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
1127
696
17.36
307.65
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3458
50419
0.39
307.65
3.7
4.8
mmol/l
4.4
4.4
1.71
2966
45272
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3395
49854
0.39
307.65
3.7
4.7
mmol/l
1.4
1.4
4.37
2870
44370
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3373
49737
0.39
307.65
5.7
6.7
mmol/mol
41.6
41.3
0.94
2915
44746
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1071
1474
7.65
307.65
1.4
1.6
—
—
—
0
0
(4035726)
2152
4732
5.39
307.65
1.4
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
587
984
5.93
306.66
1.8
2.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
4527
57478
0.42
306.17
41.2
26.5
e12/l
4.2
4.4
77.27
4354
55153
(3000963) Hemoglobin [Mass/volume] in Blood
4528
57485
0.42
306.13
41.5
26.6
g/l
125.5
132.5
165.78
4425
56110
(3035941) MCH [Entitic mass]
4527
57476
0.42
306.07
41.1
26.3
pg
30.1
30.5
35.32
4419
56111
(3024731) MCV [Entitic volume]
4528
57474
0.42
305.61
41.1
26.4
fl
91.6
91.9
4.35
4421
56113
(3010813) Leukocytes [#/volume] in Blood
4531
57494
0.42
305.46
41.3
26.5
e9/l
8.2
7.0
67.19
4355
55202
(3007461) Platelets [#/volume] in Blood
4528
57465
0.42
305.18
41.3
26.5
e9/l
271.2
234.9
151.08
4379
55417
(3023103) Potassium [Moles/volume] in Serum or Plasma
4511
56491
0.45
266.88
31.8
21.8
mmol/l
4.0
4.0
0.70
4374
54682
(3019550) Sodium [Moles/volume] in Serum or Plasma
4512
56416
0.45
263.30
31.7
21.6
mmol/l
138.2
139.6
146.31
4389
54696
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
601
1200
4.97
258.41
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4430
55632
0.46
257.69
18.6
11.1
u/l
25.5
24.9
0.23
4322
52851
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1728
6905
2.69
257.47
3.4
3.9
ug/l
64.2
20.5
3.07
1580
5715
(3035637) Corticotropin [Mass/volume] in Plasma
398
564
6.88
244.33
1.7
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3562
47881
0.47
238.45
5.4
4.6
mu/l
1.9
2.1
3.30
3108
42301
(40761511) CBC panel - Blood by Automated count
4323
53949
0.48
225.48
25.5
17.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
481
933
5.06
213.25
1.5
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1771
29864
0.43
206.33
4.1
5.5
ug/l
2.5
5.1
9.58
1486
26122
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2080
9969
2.27
202.91
4.4
2.9
mmol/l
0.8
0.8
32.41
2008
9135
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3884
49406
0.50
196.20
28.7
17.4
ml/min/173m2
77.0
71.0
63.29
3499
40945
(3003434) Protein [Mass/volume] in Pleural fluid
534
1241
4.23
189.22
1.4
1.5
g/l
38.5
30.2
43.38
499
1089
(3023199) Leukocytes [#/volume] in Pleural fluid
485
1075
4.42
182.61
1.4
1.5
e6/l
2745.7
2007.6
0.80
374
756
(3028308) Erythrocytes [#/volume] in Pleural fluid
454
977
4.54
177.35
1.4
1.5
e6/l
65710.3
72477.4
0.12
301
563
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1324
23760
0.43
170.24
3.8
4.8
%
20.5
22.3
4.24
624
12808
(3012441) Differential panel - Pleural fluid
430
952
4.40
161.90
1.4
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4513
53506
0.54
157.13
31.0
18.2
mg/l
38.3
28.6
59.53
4285
44341
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
380
838
4.40
143.62
1.2
1.3
u/l
814.2
388.0
1.53
374
784
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1761
27208
0.50
140.42
1.9
2.1
pmol/l
88.1
91.6
2.62
914
14485
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
325
661
4.75
135.70
1.2
1.3
u/l
12.6
13.3
0.22
316
598
(4010399)
946
3777
2.51
134.97
1.4
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
363
814
4.32
134.21
1.3
1.4
mmol/l
5.9
6.4
1.69
344
747
(3045788) Cell count panel - Pleural fluid
367
830
4.28
134.20
1.4
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2932
38415
0.56
131.57
4.7
3.7
pmol/l
15.3
15.1
2.99
2610
33727
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
585
13535
0.36
129.12
1.6
1.6
mmol/l
1.4
1.3
2.20
497
11098
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1027
4421
2.34
123.52
5.4
2.1
nmol/l
428.2
370.6
11.18
986
3981
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
899
16694
0.44
115.09
2.8
3.3
ug/l
0.8
0.9
0.29
609
12085
(3003338) MCHC [Mass/volume]
3343
41425
0.59
112.49
38.6
24.0
g/l
328.2
331.4
66.00
3283
40826
(3020682) Albumin/Creatinine [Ratio] in Urine
1231
20270
0.49
111.56
3.5
4.0
mg/mmol
13.2
10.2
1.00
761
13001
(3009508) Creatinine [Moles/volume] in Urine
1151
19297
0.49
109.60
2.7
3.2
mmol/l
7.2
7.3
0.48
887
15713
(3012516) Albumin [Mass/volume] in Urine
1142
19092
0.49
107.32
2.8
3.2
mg/l
415.2
334.3
0.26
740
12426
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
258
532
4.65
105.83
1.3
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3793
45223
0.60
105.44
31.1
19.6
%
37.6
38.3
4.08
2374
27001
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1453
22350
0.53
104.64
2.0
2.1
nmol/l
75.2
79.1
5.36
1247
19228
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
272
603
4.33
101.90
1.3
1.4
u/l
10.9
13.7
12.17
263
576
(3009261) Glucose [Presence] in Urine by Test strip
1993
27677
0.57
98.66
3.6
4.0
estimate
0.0
0.0
1.34
439
5020
(3021601) Nitrite [Presence] in Urine by Test strip
1958
27296
0.57
98.16
4.8
5.3
estimate
0.0
0.0
0.00
460
5169
(3035350) Ketones [Presence] in Urine by Test strip
1967
27317
0.57
96.75
3.6
4.0
estimate
0.0
0.0
0.00
458
5124
(3037467) Urinalysis macro (dipstick) panel - Urine
3226
39452
0.62
93.94
4.2
4.6
—
—
—
0
0
(3035880) pH of Pleural fluid
231
482
4.58
93.36
1.2
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
284
707
3.85
90.99
1.3
1.3
u/l
13.9
11.1
2.05
231
559
(3044889) 12 lead EKG panel
3200
38965
0.62
89.16
4.7
4.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3505
41702
0.63
87.07
36.6
22.0
%
14.6
14.0
91.07
3443
40536
(3021960) Folate [Moles/volume] in Serum or Plasma
969
16134
0.50
85.90
1.5
1.6
nmol/l
19.2
19.7
0.59
850
13631
(1761868) Lipid panel - Serum or Plasma
799
14070
0.48
83.34
3.0
3.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1453
8159
1.81
81.43
4.1
3.8
u/l
258.1
247.2
1.26
1403
7580
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1466
21006
0.58
75.56
4.0
4.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
267
726
3.52
75.15
2.8
3.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2833
19376
1.56
72.67
6.5
5.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1637
22460
0.60
69.54
2.5
2.9
ug/l
243.1
166.6
11.00
1466
20068
(3023419) Bacteria identified in Sputum by Culture
277
836
3.17
66.03
1.7
2.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
127
227
5.30
61.47
1.3
1.4
u/l
27.9
33.3
0.98
121
183
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1637
10183
1.63
61.07
2.0
1.9
s
29.9
30.3
2.72
1610
9860
(3031040) Bacteria [#/volume] in Urine by Automated count
3394
39199
0.68
61.01
4.5
5.0
e6/l
176.0
1275.6
4.33
68
767
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1865
24259
0.64
60.41
2.5
2.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
930
14326
0.56
59.74
1.6
1.8
pmol/l
14670704.4
24422170.0
0.28
743
11457
(3018418) pH of Serum or Plasma
2622
18466
1.48
54.70
5.4
4.0
ph
7.4
7.4
1.46
488
3534
(3026493) Urate [Moles/volume] in Serum or Plasma
1124
16112
0.60
53.95
2.6
2.9
umol/l
3166.3
6036.8
2.04
928
13505
(3023323) Follitropin [Units/volume] in Serum or Plasma
187
508
3.50
52.73
1.3
1.3
iu/l
30.9
35.3
0.80
146
426
(3019150) Specific gravity of Urine by Refractometry
804
12453
0.56
51.52
4.0
4.4
kg/l
1.0
1.0
0.14
139
1948
(3022096) Basophils/100 leukocytes in Blood
3364
25048
1.43
51.38
6.9
5.7
%
0.6
0.6
6.11
3263
22944
(3001893) Eosinophils/100 leukocytes in Pleural fluid
133
294
4.28
50.06
1.3
1.4
%
4.6
2.1
1.71
122
238
(3029937) Albumin [Presence] in Urine by Test strip
1091
15441
0.61
48.80
3.9
4.3
estimate
0.0
0.0
0.37
391
4812
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
125
269
4.40
48.69
1.2
1.3
ug/l
467.8
371.6
0.19
104
123
(3013707) Erythrocyte sedimentation rate by Westergren method
3632
40479
0.72
46.77
5.0
4.2
mm/h
22.8
14.7
83.28
3413
36605
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
143
352
3.85
46.60
1.3
1.4
%
66.4
67.2
0.10
125
274
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
706
3739
1.84
46.28
7.8
7.7
mmol/l
24.9
24.2
8.97
678
3391
(3019069) Monocytes/100 leukocytes in Blood
3420
25868
1.40
46.15
7.1
6.0
%
9.0
9.0
0.08
3317
23740
(3006504) Eosinophils/100 leukocytes in Blood
3399
25744
1.40
45.20
6.9
5.6
%
2.4
2.9
35.11
3295
23549
(3023368) Bacteria identified in Blood by Culture
2736
20036
1.41
43.92
4.8
4.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
704
3787
1.81
43.78
6.5
6.4
mmol/l
25.7
24.7
11.41
698
3742
(3023383) Lactate [Moles/volume] in Pleural fluid
118
267
4.18
43.13
1.2
1.3
mmol/l
3.4
3.6
0.37
111
235
(3019309) Folate [Moles/volume] in Red Blood Cells
1089
15030
0.63
42.71
1.8
1.8
nmol/l
1068.3
1151.1
2.24
813
11087
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2669
31019
0.71
42.60
4.6
3.1
u/l
72.7
57.6
5.61
2446
27880
(3002030) Lymphocytes/100 leukocytes in Blood
3439
26286
1.38
42.38
7.0
5.8
%
21.7
25.5
70.96
3330
23927
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
156
450
3.29
40.12
1.5
1.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
112
259
4.09
39.80
1.3
1.4
%
15.7
21.7
1.76
107
230
(3033658) Prothrombin time (PT) actual/Normal
2071
14638
1.43
39.75
5.4
4.0
%
91.0
81.8
55.98
2034
14252
(3011397) Hemoglobin [Presence] in Urine by Test strip
944
13170
0.63
38.17
3.3
3.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1352
17467
0.67
37.80
2.1
2.3
mg/l
3.5
3.1
4.78
1140
14601
(3013512) EKG study
1492
18913
0.68
37.75
4.5
4.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1044
14197
0.64
37.46
3.6
3.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
3499
27186
1.35
37.21
6.8
5.3
e9/l
0.7
0.6
37.31
3072
22936
(40758558) Short blood count panel - Blood
1965
13897
1.42
37.17
11.2
6.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
3337
25827
1.35
36.02
6.8
5.6
%
62.8
59.0
53.46
3232
23647
(3006315) Basophils [#/volume] in Blood
3511
27387
1.34
35.95
6.8
5.3
e9/l
0.0
0.0
3.20
3095
23140
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
465
7523
0.55
33.34
3.4
4.9
%
33.0
33.3
0.26
304
4851
(3019198) Lymphocytes [#/volume] in Blood
3535
27811
1.33
33.24
6.9
5.4
e9/l
1.7
1.9
2.18
3140
23866
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
604
9088
0.59
32.99
1.2
1.2
u/ml
2.2
1.8
0.26
110
2219
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
263
1106
2.26
32.53
1.4
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
3952
31664
1.32
32.32
15.0
8.2
e9/l
5.0
4.4
35.16
3569
27215
(44786800) Granulocytes/100 leukocytes in Body fluid
65
114
5.37
32.23
1.3
1.3
%
17.8
17.1
0.07
59
77
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
314
1425
2.10
32.11
1.4
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1236
8210
1.48
32.08
7.0
6.3
mmol/l
1.6
1.0
5.81
1039
6227
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
324
1497
2.07
31.60
1.4
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
3566
28221
1.32
31.60
7.0
5.5
e9/l
0.2
0.2
5.78
3161
24151
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
232
939
2.35
31.38
1.4
1.6
iu/l
3.0
4.5
1.90
40
279
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1232
8239
1.47
30.78
7.0
6.2
kpa
5.3
5.0
17.14
1162
7768
(3027801) Oxygen [Partial pressure] in Arterial blood
1230
8237
1.47
30.49
7.0
6.2
kpa
11.1
11.7
5.15
1160
7758
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
501
2712
1.77
30.26
2.3
2.7
u/ml
0.3
0.3
1.01
283
1541
(3026008) Bacteria identified in Urine by Culture
1617
19561
0.72
29.68
3.1
3.4
—
—
—
0
0
(3000492) Spirometry study
674
3975
1.64
29.67
1.6
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1699
12114
1.39
29.64
5.5
3.1
mmol/l
2.5
2.5
59.35
1552
10352
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
516
7866
0.59
29.40
12.2
8.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
89
218
3.85
29.33
1.3
1.4
%
17.8
20.9
0.52
78
172
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
249
1074
2.20
29.00
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
206
855
2.29
26.34
1.4
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1286
8916
1.41
26.06
1.9
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
223
966
2.19
25.73
1.5
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3822
31069
1.28
25.55
10.6
5.9
umol/l
9.9
12.7
29.31
3722
29299
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
209
893
2.22
24.95
1.5
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
540
3147
1.65
24.84
2.0
1.8
ug/l
1.9
2.6
0.60
487
2692
(40768804) Tissue Pathology biopsy report
2763
21673
1.29
24.12
2.8
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2259
25423
0.77
23.81
4.5
4.4
ng/l
40.1
89.2
2.15
1847
20054
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2163
16453
1.31
23.76
4.6
3.1
u/l
32.6
37.2
1.43
2076
15386
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
206
896
2.18
23.56
1.5
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3412
27551
1.27
23.32
7.5
11.8
inr
1.2
1.4
22.62
716
7551
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
520
7504
0.62
23.25
1.2
1.3
iu/ml
54.0
40.6
0.81
152
2264
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
266
4563
0.53
22.92
1.6
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
592
3631
1.57
21.99
9.6
8.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3517
28644
1.26
21.86
7.8
5.9
mmol/l
1.2
1.2
10.94
3353
25514
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
359
1953
1.75
21.30
1.4
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1954
22168
0.77
21.26
2.9
3.3
ng/l
1511.7
2105.1
8.54
1761
19220
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
489
7017
0.63
21.22
1.2
1.2
u/ml
26.1
14.9
0.42
124
2413
(3019060) Gas panel - Arterial blood
752
4922
1.47
20.52
4.3
4.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
173
743
2.20
20.47
2.7
4.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
305
1607
1.80
20.19
4.8
4.6
mmol/l
3.0
2.6
1.38
243
1074
(3013290) Carbon dioxide [Partial pressure] in Blood
305
1608
1.80
20.15
4.8
4.6
kpa
5.1
5.0
1.76
300
1561
(3027315) Oxygen [Partial pressure] in Blood
306
1616
1.80
20.10
4.8
4.6
kpa
8.1
8.3
2.33
301
1568
(40761535) Cells panel - Urine sediment
369
5518
0.61
19.04
3.6
3.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
122
2529
0.44
18.33
1.8
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
108
396
2.57
18.24
1.7
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
315
4837
0.59
18.09
1.9
2.0
ug/g
219.4
169.5
0.92
250
3697
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
309
1689
1.74
18.07
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
108
398
2.56
18.06
1.7
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
309
1690
1.74
18.03
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
135
557
2.29
17.64
1.2
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
119
465
2.41
17.59
1.6
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
232
1175
1.87
17.48
2.3
3.6
%
1.6
1.6
0.05
202
866
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
236
3875
0.56
17.43
1.4
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
880
6101
1.39
17.38
6.8
5.9
mmol/l
1.3
1.4
1.79
839
5778
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
163
734
2.10
17.17
1.5
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
101
370
2.57
17.11
1.1
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
626
8198
0.69
17.05
1.4
1.5
g/l
2.8
2.8
0.14
338
4634
(3041918) Cholesterol [Moles/volume] in Pleural fluid
56
146
3.61
17.03
1.1
1.2
mmol/l
2.1
1.4
3.93
49
86
(3010421) pH of Blood
325
1834
1.68
16.94
4.9
4.4
ph
7.4
7.4
1.14
300
1564
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
138
588
2.22
16.73
1.2
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4318
44165
0.82
16.57
14.9
7.5
u/l
89.5
82.4
14.44
4215
41074
(3022217) INR in Platelet poor plasma by Coagulation assay
878
10808
0.73
16.45
25.4
30.9
inr
1.4
1.5
1.07
115
1473
(1616796) Gas panel - Central venous blood
296
1655
1.70
15.98
3.9
3.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
435
5994
0.66
15.40
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
100
392
2.40
14.75
4.3
3.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1012
7363
1.33
14.51
7.8
6.5
%
94.6
95.1
1.46
976
7066
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
52
145
3.37
14.35
1.4
1.4
%
8.4
7.2
0.16
39
62
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3736
31485
1.20
14.30
8.8
6.7
mmol/l
1.2
1.2
7.35
3178
26131
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
129
573
2.12
14.16
1.6
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
203
3247
0.57
13.63
1.2
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
121
538
2.12
13.28
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
121
538
2.12
13.28
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
121
538
2.12
13.28
1.3
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
904
6558
1.32
13.18
8.4
7.0
g/l
120.5
119.8
0.54
875
6323
(3000991) Gas panel - Venous blood
800
5702
1.35
13.16
7.8
7.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
102
425
2.26
13.14
2.8
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
241
3654
0.61
13.12
2.6
2.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
276
4048
0.63
13.05
2.5
3.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
910
10799
0.76
12.92
2.1
2.6
umol/l
9.9
12.0
15.18
849
9820
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
1238
0.34
12.79
1.4
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
500
3313
1.44
12.73
4.3
3.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
229
3484
0.60
12.65
3.9
3.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
62
208
2.80
12.57
1.1
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
847
10062
0.76
12.06
2.1
2.5
g/l
2.2
2.2
2.10
787
9164
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1787
19479
0.82
11.98
2.3
2.2
u/l
148.9
228.1
11.26
1686
18103
(3015377) Calcium [Moles/volume] in Serum or Plasma
2514
20680
1.20
11.92
5.6
3.2
mmol/l
2.4
2.3
17.03
2313
17395
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
107
1987
0.50
11.89
1.7
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
191
2977
0.59
11.64
2.3
2.4
au/ml
20.1
24.3
—
9
85
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1498
11778
1.23
11.21
1.9
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
624
7651
0.74
11.10
1.3
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
375
2421
1.47
10.98
2.0
2.2
ug/l
370.7
665.8
1.01
335
2294
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
169
2674
0.58
10.93
1.2
1.3
au/ml
25.1
60.0
—
9
101
(36660697) Celiac disease serology panel - Serum
219
3250
0.62
10.92
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
102
1862
0.51
10.79
1.0
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1789
14368
1.21
10.79
2.5
2.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
49
159
2.89
10.61
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
1012
7675
1.27
10.40
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
594
4193
1.35
10.40
1.6
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
719
5226
1.31
10.29
2.8
2.3
u/l
33.2
38.0
1.35
636
4393
(4034850)
101
1817
0.51
10.23
14.1
12.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
625
4461
1.34
10.16
4.0
3.7
mmol/l
2.4
1.8
3.82
516
3207
(3014891) Appearance of Pleural fluid
48
158
2.85
10.15
1.6
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
812
9492
0.78
10.08
2.2
2.6
%
18.7
21.7
6.84
719
7920
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
64
246
2.44
9.99
1.2
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
64
246
2.44
9.99
1.2
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
108
1885
0.53
9.93
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
28
843
0.31
9.85
1.3
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
642
4622
1.32
9.83
4.1
3.7
ph
7.4
7.4
0.37
65
578
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
64
248
2.42
9.83
1.2
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
77
324
2.23
9.81
1.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
77
325
2.23
9.74
1.2
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
77
325
2.23
9.74
1.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
77
325
2.23
9.74
1.2
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
36
946
0.35
9.64
1.4
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
122
615
1.87
9.53
2.9
3.7
u/ml
43.1
34.3
0.41
117
597
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
100
1763
0.52
9.52
1.3
1.3
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
28
69
3.81
9.35
1.0
1.1
iu/ml
39.5
7.5
—
10
30
(40768795) Lymph node Pathology biopsy report
107
521
1.93
9.29
1.2
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
411
5216
0.72
9.14
2.0
2.3
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
35
102
3.22
9.13
5.4
3.8
u/l
28.5
43.3
1.63
20
32
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
642
4679
1.31
9.01
4.1
3.7
kpa
5.3
5.1
2.69
602
4272
(3017446) Testosterone [Moles/volume] in Serum or Plasma
318
4198
0.70
8.95
1.7
2.1
nmol/l
9.0
11.3
5.80
258
3543
(44790048)
120
615
1.84
8.93
1.3
1.4
—
—
—
0
0
(44790047)
120
615
1.84
8.93
1.3
1.4
—
—
—
0
0
(44806118)
120
615
1.84
8.93
1.3
1.4
—
—
—
0
0
(44790049)
120
615
1.84
8.93
1.3
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1045
8099
1.24
8.81
1.9
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
93
449
1.95
8.33
1.2
1.2
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
31
89
3.27
8.30
1.2
1.2
mg/l
7.0
8.5
0.47
31
82
(4094501)
76
1395
0.51
8.28
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
261
3520
0.68
8.28
3.1
2.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
195
1166
1.58
8.26
1.4
1.3
mmol/l
66.7
62.1
0.84
154
937
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
563
6717
0.77
8.15
2.2
2.5
ug/l
5.1
6.7
1.17
480
5666
(3014576) Chloride [Moles/volume] in Serum or Plasma
1089
8561
1.22
7.98
7.4
6.3
mmol/l
103.5
104.5
8.57
1067
8347
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
76
347
2.06
7.96
1.8
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2121
22153
0.86
7.96
3.6
4.1
e6/l
71.9
125.2
2.78
1627
16627
(3024561) Albumin [Mass/volume] in Serum or Plasma
3181
27304
1.15
7.91
6.0
4.7
g/l
32.4
34.2
50.33
2996
24910
(3052851) Hemolysis interference index of Serum or Plasma
297
1968
1.43
7.68
3.9
3.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1036
8146
1.22
7.56
1.8
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
375
4677
0.74
7.47
5.0
2.8
ml/min/173m2
59.6
59.3
0.07
151
2071
(4024509)
22
634
0.32
7.23
1.5
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
799
6145
1.24
7.21
1.8
2.5
g/l
64.7
65.9
4.09
736
5443
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
28
715
0.36
7.17
1.9
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
44
167
2.47
7.16
1.5
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
573
6704
0.78
7.09
2.3
2.5
e9/l
70.6
66.8
1.46
386
5174
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
55
1057
0.48
6.94
1.9
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
72
341
1.98
6.89
2.2
3.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
74
354
1.96
6.88
1.7
2.0
%
33.0
40.0
—
5
40
(3017181) Myelocytes/100 leukocytes in Blood
659
4988
1.26
6.87
3.0
3.9
%
1.1
1.0
1.02
356
1525
(3006184) Hemoglobin [Mass/volume] in Capillary blood
248
1631
1.44
6.73
2.0
2.3
g/l
119.3
126.5
2.81
126
1206
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
64
1154
0.52
6.68
1.1
1.3
u/l
40.4
40.4
0.00
53
990
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
23
63
3.42
6.66
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
81
1356
0.55
6.61
2.0
2.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
84
1384
0.56
6.48
1.2
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
234
1536
1.44
6.44
2.5
2.6
%
14.5
15.8
3.53
93
835
(21494814) CD8 cells/100 lymphocytes in Specimen
46
188
2.30
6.41
1.6
2.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
79
397
1.87
6.38
2.3
3.8
u/ml
54.9
42.3
0.40
79
390
(3044640) Blood type and Crossmatch panel - Blood
2247
19056
1.14
6.36
2.7
2.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
510
5963
0.79
6.28
1.3
1.3
titre
496.7
500.2
0.02
132
1315
(3017354) Segmented neutrophils/100 leukocytes in Blood
125
722
1.63
6.22
2.1
3.5
%
59.4
60.6
0.21
97
424
(3011412) CD3 cells [#/volume] in Blood
85
441
1.81
6.22
1.9
2.0
e9/l
0.9
1.1
1.67
57
270
(3003694) ABO and Rh group [Type] in Blood
1215
13010
0.85
6.06
1.3
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
257
1737
1.40
6.02
3.0
2.9
kpa
7.6
7.7
0.57
237
1601
(3008898) HLA-B27 [Presence]
48
910
0.49
5.89
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
225
1494
1.42
5.85
2.7
2.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
121
706
1.61
5.81
4.2
3.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
384
2776
1.31
5.81
4.8
4.1
mmol/l
25.7
24.7
6.78
365
2486
(3017732) Neutrophils [#/volume] in Blood
291
3614
0.74
5.69
4.0
3.3
e9/l
5.1
4.2
3.36
220
2511
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
415
4910
0.78
5.65
2.8
3.9
ng/l
84.1
102.0
4.59
360
4108
(3016228) CD19 cells/100 cells in Blood
46
199
2.17
5.65
1.7
1.9
%
7.9
8.3
0.09
46
188
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
125
1802
0.64
5.64
1.7
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
269
3365
0.74
5.53
4.5
4.2
%
50.8
46.5
2.36
269
3320
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
28
97
2.71
5.53
1.1
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
205
1356
1.42
5.47
1.2
1.2
—
—
—
0
0
(4146454)
38
759
0.47
5.45
2.4
2.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
613
4726
1.23
5.44
3.0
3.9
%
0.2
0.1
0.70
329
1413
(4015189)
43
184
2.19
5.44
2.0
2.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
359
4303
0.77
5.43
3.5
3.3
g/l
123.3
127.0
2.35
353
4196
(3001019) Free T4 and TSH panel - Serum or Plasma
48
883
0.51
5.42
1.7
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
79
1255
0.58
5.39
1.6
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
148
2040
0.67
5.39
4.7
4.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
199
2595
0.71
5.33
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
82
1286
0.59
5.33
1.1
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
169
2265
0.69
5.30
2.4
2.9
g/l
0.4
0.3
0.33
84
958
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
198
1312
1.42
5.25
1.8
2.3
%
219.4
209.2
0.89
186
1244
(3000850) Epithelial cells [#/volume] in Urine
1350
14191
0.87
5.20
2.6
2.8
e6/l
6.2
4.1
6.53
1214
12457
(3000475) Leukocytes [#/volume] in Synovial fluid
103
1514
0.63
5.12
1.6
1.5
e6/l
35069.3
15057.8
0.80
80
1073
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
235
2961
0.73
5.10
2.0
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
235
2956
0.74
5.05
2.0
2.2
g/l
4.0
3.8
1.12
180
2053
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
326
2354
1.31
5.02
2.6
3.2
u/ml
667.8
2859.6
1.06
270
2008
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
236
2963
0.74
5.01
2.0
2.2
g/l
8.1
7.4
5.24
184
2125
(40768441) Liver Pathology biopsy report
66
341
1.82
4.98
1.2
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
100
586
1.60
4.80
1.3
1.3
mosm/kgh2o
268.6
278.3
5.03
80
427
(3002179) Metamyelocytes/100 leukocytes in Blood
576
4476
1.22
4.76
3.0
3.7
%
0.6
0.6
0.05
267
1052
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
240
1672
1.35
4.75
2.3
4.0
u/ml
86.1
72.2
0.34
231
1604
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
63
327
1.81
4.70
1.7
1.9
%
15.7
15.6
0.01
15
126
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
44
788
0.52
4.63
1.5
1.5
%
71.3
63.9
0.92
32
502
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
311
3712
0.78
4.60
1.4
1.6
g/l
2.0
1.6
8.81
257
3121
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
40
736
0.51
4.58
1.5
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
36
678
0.49
4.44
1.1
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
258
0.29
4.38
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
261
0.29
4.36
1.0
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
196
2467
0.74
4.28
2.4
3.1
ratio
4.9
3.2
—
10
180
(3027273) Bicarbonate [Moles/volume] in Venous blood
309
3645
0.78
4.18
3.9
3.5
mmol/l
26.0
25.0
4.51
303
3528
(3027945) Reticulocytes/100 erythrocytes in Blood
835
8948
0.86
4.15
2.2
2.3
%
1.8
1.7
0.30
733
7713
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
222
2731
0.75
4.15
2.1
2.3
g/l
3.5
3.1
6.95
183
2090
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
41
193
1.99
4.14
1.1
2.0
u/ml
2102.3
19454.3
—
8
32
(3034860) Kappa light chains.free [Mass/volume] in Serum
204
2537
0.75
4.12
2.4
3.1
mg/l
50.1
89.4
1.05
153
2054
(3042111) Morphology [Interpretation] in Bone marrow Narrative
86
1247
0.64
4.10
1.4
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
34
633
0.50
4.08
1.6
2.1
u/field
3.6
1.9
0.49
13
240
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
60
323
1.74
4.02
1.6
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
128
1704
0.70
3.97
1.3
1.5
ug/g
274.8
258.9
0.37
72
1036
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
205
2532
0.75
3.96
2.4
3.1
mg/l
40.0
53.9
0.85
155
2049
(1002224) Polysomnography panel
80
1167
0.64
3.94
1.1
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
50
257
1.82
3.91
2.4
3.9
%
58.3
54.2
0.54
50
246
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
57
305
1.75
3.91
2.3
2.1
e6/l
571.4
580.7
0.03
24
134
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
69
1039
0.62
3.91
1.4
1.4
nmol/l
1.1
0.8
0.71
53
856
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
54
863
0.58
3.89
1.1
1.2
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
8
10
7.49
3.87
1.1
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
147
981
1.41
3.86
3.4
4.7
iu/ml
602.4
2908.3
0.71
22
149
(3036489) Thrombin time
256
1865
1.29
3.79
1.6
1.9
s
21.9
21.8
0.07
237
1683
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
17
56
2.84
3.74
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
132
1715
0.72
3.59
2.4
2.2
ug/min
94.2
109.0
0.35
75
968
(3000012) Reticulocyte production index
21
441
0.44
3.58
1.6
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
77
1105
0.65
3.56
1.3
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
250
0.34
3.54
2.0
2.7
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
208
1492
1.31
3.48
1.8
2.2
g/l
4.0
3.6
2.74
197
1400
(3000034) Microalbumin [Mass/volume] in Urine
36
618
0.54
3.40
1.9
3.1
mg/l
21.0
53.6
2.04
29
475
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
543
0.52
3.37
1.4
1.4
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
14
44
2.98
3.35
1.1
1.0
g/l
0.1
0.1
0.05
14
31
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
20
415
0.45
3.33
1.1
1.1
u/ml
4.3
3.2
—
7
105
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
362
4083
0.82
3.31
1.7
1.7
%
1.8
1.6
2.80
286
3331
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
35
598
0.55
3.27
1.4
1.5
%
19.5
25.4
0.77
23
382
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
413
3233
1.21
3.26
2.8
3.9
mmol/l
24.5
24.0
2.32
392
2869
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
234
2761
0.79
3.25
2.0
2.2
g/l
10.2
10.5
0.46
195
2275
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
175
1239
1.33
3.24
1.3
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
36
178
1.90
3.23
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
89
1214
0.68
3.23
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
70
1000
0.65
3.20
2.8
3.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
208
2479
0.78
3.15
2.2
2.3
g/l
1.0
1.2
0.39
175
2061
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
126
1610
0.73
3.14
1.8
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
131
1659
0.73
3.09
4.5
3.7
mmol/l
7.4
7.8
1.77
131
1624
(3037556) Urate [Mass/volume] in Serum or Plasma
8
215
0.35
3.05
2.9
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
56
829
0.63
3.04
1.3
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
265
2007
1.24
2.93
3.3
3.2
mmol/l
25.6
24.7
2.22
227
1745
(3025941) Bacteria identified in Stool by Culture
233
2712
0.80
2.91
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
54
796
0.63
2.89
1.8
1.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
70
974
0.67
2.86
1.1
1.2
—
11.5
—
0
10
(3001964) Herpes simplex virus Ag [Presence] in Specimen
30
146
1.93
2.85
1.1
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
599
4901
1.15
2.82
1.5
1.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
25
447
0.52
2.77
1.7
2.0
ug/l
2.3
2.1
0.17
20
369
(3021788) Differential panel - Synovial fluid
84
1119
0.70
2.74
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
108
1372
0.73
2.65
1.8
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
435
4724
0.85
2.64
1.3
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
54
776
0.65
2.61
1.2
1.2
u/ml
91.8
46.0
—
6
86
(3051387) C reactive protein [Mass/volume] in Capillary blood
117
1463
0.74
2.59
3.7
3.8
mg/l
45.7
31.3
2.20
85
976
(3044941) Cell count panel - Synovial fluid
71
964
0.69
2.59
1.3
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
47
271
1.63
2.57
2.8
2.6
%
38.1
36.3
0.15
12
103
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
63
390
1.51
2.55
1.2
1.2
titre
167.7
117.5
0.21
13
64
(3002582) Erythrocytes [#/volume] in Urine
2000
19879
0.92
2.55
3.2
3.6
e6/l
80.1
114.6
0.86
1587
15719
(40757494) Bilirubin.total [Moles/volume] in Blood
19
360
0.49
2.54
2.3
2.1
—
27.7
—
0
36
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
91
1177
0.72
2.52
1.3
1.2
mg/l
842.6
588.4
0.41
86
1093
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2706
26576
0.93
2.51
4.2
4.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
26
444
0.55
2.51
4.6
11.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
29
479
0.56
2.49
1.2
1.2
mmol/l
8.9
7.7
0.69
20
337
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
47
687
0.64
2.48
1.0
1.1
iu/ml
9.3
306.1
0.63
12
129
(21494434) Karyotype in Bone marrow
41
618
0.62
2.47
1.0
1.2
—
—
—
0
0
(3036603) Volume of Urine
61
379
1.51
2.45
1.2
1.7
ml
2012.8
1853.9
0.41
33
106
(3009466) Valproate [Moles/volume] in Serum or Plasma
53
749
0.66
2.40
3.7
3.9
umol/l
364.5
333.5
0.69
44
617
(3046861) Legionella sp Ag [Presence] in Urine
11
37
2.78
2.38
1.2
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
33
518
0.59
2.36
1.2
1.2
—
54.5
—
0
33
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
18
78
2.16
2.35
1.2
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
22
385
0.53
2.33
2.0
1.9
—
73.2
—
0
18
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
665
6944
0.89
2.32
4.8
3.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
639
6686
0.89
2.31
2.8
3.2
ng/l
224.9
279.9
2.51
589
6131
(3019225) pH of Specimen
635
6646
0.88
2.30
5.6
4.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
530
4373
1.14
2.27
3.1
3.9
%
0.0
0.3
1.51
289
1156
(3007566) Smooth muscle Ab [Titer] in Serum
96
1208
0.74
2.27
1.2
1.2
titre
175.5
105.4
0.45
11
79
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
15
61
2.30
2.27
1.3
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
15
61
2.30
2.27
1.3
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
15
61
2.30
2.27
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1079
10961
0.91
2.26
2.8
3.0
e6/l
1.1
1.2
0.46
593
6548
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
77
1002
0.72
2.25
1.2
1.3
e6/l
44.1
25.9
0.20
51
768
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
77
1001
0.72
2.24
1.3
1.4
e6/l
33622.9
1114.2
0.49
53
813
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
58
0.00
2.23
0.0
4.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
59
0.00
2.21
0.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
92
1159
0.74
2.20
1.2
1.2
u/ml
22.2
38.1
—
10
58
(4211845)
18
327
0.51
2.17
3.8
3.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
37
547
0.63
2.10
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
16
298
0.50
2.09
2.5
4.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
23
116
1.86
2.04
1.3
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
43
608
0.66
2.01
1.2
1.2
nmol/l
258.8
322.0
1.42
28
456
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
87
1085
0.75
1.98
1.2
1.2
u/ml
2.5
6.1
0.73
11
107
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
73
934
0.73
1.97
1.1
1.2
u/ml
1.0
5.8
—
6
67
(3010144) Erythrocytes [#/volume] in Synovial fluid
45
626
0.67
1.95
1.4
1.3
e6/l
213324.3
169482.3
0.11
32
421
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
82
1026
0.75
1.92
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
167
1913
0.81
1.92
2.4
3.2
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
15
3.74
1.91
1.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
15
3.74
1.91
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
89
1099
0.75
1.90
1.2
1.2
u/ml
11.9
5.7
0.88
20
175
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
148
0.38
1.88
1.2
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
203
2274
0.83
1.87
2.1
2.1
g/l
36.3
37.0
0.89
177
1887
(3004716) Salmonella sp identified in Stool by Organism specific culture
159
1824
0.81
1.86
1.2
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
51
326
1.47
1.86
1.1
1.2
u/l
32.0
28.5
0.17
44
275
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
65
435
1.40
1.86
1.1
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
51
0.00
1.85
0.0
3.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
55
728
0.70
1.84
1.1
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
83
1028
0.75
1.83
1.2
1.2
mmol/l
3.8
3.9
0.88
76
944
(3019420) Tryptase [Mass/volume] in Serum or Plasma
10
208
0.45
1.81
1.6
1.5
ug/l
8.8
8.9
—
10
180
(3005719) IgG [Mass/volume] in Serum or Plasma
357
3811
0.87
1.81
2.2
2.6
g/l
10.0
10.7
2.50
323
3425
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
171
1314
1.22
1.78
1.7
1.8
mg/l
11.2
12.7
1.52
160
1197
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
376
0.60
1.78
1.1
1.1
u/ml
0.7
1.5
—
9
143
(3036670) Protein [Mass/volume] in Synovial fluid
12
231
0.49
1.77
1.2
1.1
g/l
44.7
40.6
—
5
115
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
6
143
0.39
1.76
1.0
1.2
%
—
28.8
—
0
20
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
43
589
0.68
1.75
1.4
1.7
u/ml
24.9
27.4
0.12
11
137
(3047181) Lactate [Moles/volume] in Blood
263
2109
1.17
1.73
7.0
5.9
mmol/l
1.2
1.4
3.61
221
1876
(3028026) IgM [Mass/volume] in Serum or Plasma
279
3018
0.86
1.72
1.9
1.9
g/l
1.5
1.4
0.17
252
2669
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
46
619
0.69
1.71
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
73
910
0.75
1.70
1.1
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
50
662
0.70
1.70
1.1
1.2
u/ml
256.0
303.9
0.79
31
388
(3004451) EKG impression Narrative
56
372
1.41
1.70
1.5
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1464
12913
1.07
1.69
4.5
4.2
ng/l
323.2
525.8
1.12
1278
11283
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
25
140
1.67
1.62
2.6
2.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
27
400
0.63
1.62
1.6
1.9
u/field
2.5
2.2
0.09
19
273
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
53
352
1.41
1.62
1.5
1.6
u/l
5.8
6.5
0.12
32
164
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
119
1383
0.80
1.62
1.6
1.4
g/l
1.1
1.2
0.64
109
1300
(3008152) Bicarbonate [Moles/volume] in Arterial blood
541
4580
1.11
1.60
7.5
6.6
mmol/l
25.6
24.4
11.74
506
4282
(40761536) Microorganisms panel - Urine sediment
468
4862
0.89
1.57
3.9
4.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
111
1295
0.80
1.57
1.3
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
370
3071
1.13
1.54
1.9
2.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
19
2.96
1.54
1.0
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
145
1641
0.82
1.54
1.2
1.2
u/ml
0.3
1.0
2.08
11
179
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
39
0.00
1.53
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
25
371
0.63
1.53
1.6
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
697
7084
0.91
1.53
1.7
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
35
217
1.51
1.52
1.1
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
197
2164
0.85
1.51
2.1
2.2
g/l
0.2
0.0
0.34
173
1934
(3000494) Fungus identified in Specimen by Culture
717
6183
1.09
1.48
1.4
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
28
167
1.57
1.45
3.7
2.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
55
695
0.74
1.45
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
142
1598
0.83
1.44
1.1
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
50
338
1.39
1.42
1.1
1.2
u/l
96.6
98.4
0.03
45
291
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
318
0.62
1.42
1.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
11
49
2.10
1.40
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
129
0.43
1.40
1.0
1.1
miu/ml
2021.8
1578.4
—
6
129
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
166
0.51
1.40
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
328
0.63
1.39
2.0
2.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
625
5373
1.10
1.39
5.7
3.9
mmol/l
1.2
1.2
3.10
590
4636
(3019977) pH of Arterial blood
63
444
1.33
1.38
2.2
2.4
ph
7.4
7.4
0.46
23
173
(3020491) Glucose [Moles/volume] in Blood
32
439
0.68
1.38
1.9
2.2
mmol/l
7.3
7.2
0.11
24
299
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
113
0.41
1.37
1.0
1.5
ng/l
132.8
157.9
—
5
113
(3020650) Glucose [Presence] in Urine
5
114
0.41
1.37
1.4
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
76
1.85
1.37
1.3
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
115
0.41
1.37
1.0
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
44
293
1.41
1.37
2.2
2.0
e6/l
432.5
499.1
0.52
38
252
(3000093) Morphology [Interpretation] in Blood Narrative
56
698
0.75
1.36
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
360
0.65
1.36
1.5
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
360
0.65
1.36
1.5
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
32
437
0.68
1.35
1.8
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1838
17949
0.95
1.33
3.1
3.4
e6/l
0.6
0.5
1.83
1438
13896
(3016038) Potassium [Moles/volume] in Urine
60
423
1.33
1.33
1.2
1.1
mmol/l
36.3
35.3
0.12
52
356
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
40
2.11
1.30
1.0
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
81
598
1.27
1.29
1.1
1.2
u/l
66.4
61.4
0.20
66
402
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
15
78
1.80
1.28
1.2
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
19
286
0.62
1.27
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
153
1682
0.85
1.24
1.5
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
306
0.64
1.23
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
177
0.53
1.22
1.4
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
189
0.54
1.21
1.1
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
46
578
0.74
1.21
2.2
2.1
ml
621.8
650.1
0.15
28
347
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
119
1333
0.83
1.20
1.5
1.4
g/l
0.2
0.2
0.22
109
1253
(3018572) Chloride [Moles/volume] in Blood
187
1514
1.16
1.18
7.8
6.7
mmol/l
103.8
105.1
2.75
161
1362
(3039000) Anion gap in Blood
187
1514
1.16
1.18
7.8
6.7
mmol/l
10.5
11.3
3.35
161
1362
(46235355) HIV 1 and 2 tests - Meaningful Use set
549
4736
1.09
1.17
1.3
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
77
898
0.80
1.16
3.1
2.1
mg/l
31.1
26.5
0.25
25
211
(3016750) Collection duration of Urine
29
389
0.70
1.15
2.3
1.9
min
509.7
489.8
0.48
20
268
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
34
443
0.72
1.14
1.4
1.5
—
1687.3
—
0
11
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
41
280
1.37
1.14
1.2
1.3
u/ml
0.4
1.9
1.58
25
154
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
14
75
1.75
1.11
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
36
242
1.39
1.10
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
272
2273
1.12
1.10
1.2
1.2
iu/ml
140.6
121.6
0.27
50
765
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
38
1.97
1.09
1.3
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
29
381
0.71
1.04
1.1
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
237
0.63
1.04
1.1
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1758
17071
0.95
1.03
3.1
3.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
306
2587
1.11
1.02
1.4
1.5
u/ml
12.2
18.4
—
7
65
(3013826) Glucose [Moles/volume] in Serum or Plasma
3737
35706
0.96
1.02
7.0
4.8
mmol/l
6.8
6.9
3.33
3608
33581
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
13
201
0.60
1.01
2.5
1.7
ug/l
41.1
59.3
1.08
13
194
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
52
623
0.78
1.01
1.1
1.3
pmol/l
252.9
260.0
0.07
38
466
(3023183) Ammonium ion [Moles/volume] in Plasma
163
1326
1.15
1.01
2.0
2.4
umol/l
35.7
33.5
0.55
122
1081
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
101
0.46
1.01
6.4
13.3
mmol/l
5.5
5.1
—
5
101
(3028192) IgG subclass 2 [Mass/volume] in Serum
60
443
1.27
1.01
1.2
1.3
g/l
2.8
2.9
0.21
32
312
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
293
2474
1.11
1.01
3.8
3.1
pmol/l
4.2
4.3
0.93
264
2118
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
312
0.69
1.00
1.0
1.0
u/ml
0.6
1.2
—
9
124
(40768793) Breast Pathology biopsy report
73
838
0.81
0.99
1.2
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
139
1506
0.86
0.99
1.2
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
32
216
1.39
0.98
2.0
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
32
216
1.39
0.98
2.0
2.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
148
0.57
0.98
1.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
28
0.00
0.98
0.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
221
0.63
0.97
1.1
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
289
2982
0.90
0.96
6.4
4.9
%
1.9
1.6
2.70
261
2809
(3014765) Yersinia sp identified in Stool by Organism specific culture
139
1500
0.86
0.95
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
138
1489
0.86
0.94
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
112
0.50
0.93
1.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
361
0.72
0.93
1.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
12
184
0.61
0.92
2.3
1.4
umol/l
24.8
29.1
1.06
12
177
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
317
0.71
0.92
1.0
1.0
u/ml
0.8
2.6
—
8
135
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
15
217
0.65
0.91
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
92
722
1.19
0.90
2.7
3.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
285
2930
0.91
0.89
6.4
5.0
%
0.9
0.9
0.76
258
2763
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
17
103
1.54
0.89
1.5
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
59
443
1.25
0.89
1.2
1.3
g/l
6.6
7.1
0.45
31
309
(3024139) IgG subclass 3 [Mass/volume] in Serum
59
443
1.25
0.89
1.2
1.3
g/l
0.5
0.5
0.60
33
312
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
98
0.48
0.89
1.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
81
906
0.83
0.87
7.4
15.7
mmol/l
7.6
7.6
0.06
67
732
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
40
1.87
0.87
1.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
11
169
0.61
0.86
1.9
2.4
mmol/l
6.1
7.9
—
6
110
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
20
268
0.70
0.84
1.2
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
53
1.77
0.84
1.6
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
156
0.60
0.84
1.5
2.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
46
543
0.79
0.84
1.1
1.2
miu/ml
147.8
205.4
—
10
168
(3010838) Calcium [Moles/time] in 24 hour Urine
19
255
0.70
0.81
1.2
1.8
—
9.5
—
0
9
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
11
166
0.62
0.81
1.0
1.3
—
—
—
0
0
(4198724)
10
54
1.73
0.80
1.0
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
193
2009
0.90
0.79
2.1
2.2
g/l
0.0
0.0
0.40
169
1789
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
23
0.00
0.79
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
273.5
—
0
24
(44806420)
19
253
0.70
0.79
2.6
2.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
22
285
0.72
0.78
1.1
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
12
69
1.63
0.78
2.6
4.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
93
0.50
0.77
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
174
0.64
0.76
1.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
190
1973
0.90
0.76
2.1
2.2
g/l
0.0
0.0
0.00
169
1782
(4062490)
58
445
1.22
0.75
1.2
1.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
22
2.13
0.75
1.0
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
253
2162
1.10
0.75
4.4
4.0
mmol/l
4.0
3.9
0.55
235
2002
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
13
184
0.66
0.74
1.4
1.4
—
1.4
—
0
15
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
36
1.82
0.73
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
41
480
0.80
0.72
1.0
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
26
323
0.75
0.72
1.2
1.2
mmol/l
10.1
11.9
—
6
102
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
735
6544
1.06
0.72
2.5
2.7
umol/l
9.0
9.9
0.34
637
5658
(3022493) Free Hemoglobin [Mass/volume] in Plasma
22
280
0.73
0.71
1.3
3.6
mg/l
67.6
67.1
0.01
14
186
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
182
0.67
0.71
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
23
157
1.37
0.71
1.3
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
557
5511
0.94
0.70
3.0
3.1
kpa
4.5
4.4
0.52
534
5274
(4027681)
27
190
1.33
0.69
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
13
181
0.67
0.69
3.0
1.9
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
136
0.62
0.69
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
136
0.62
0.69
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
136
0.62
0.69
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
136
0.62
0.69
1.2
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
244
2093
1.09
0.68
1.6
1.7
u/l
37.4
37.9
0.15
206
1764
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
64
710
0.84
0.68
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
109
0.60
0.68
1.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2579
23601
1.03
0.68
13.6
10.5
e9/l
0.0
0.0
0.56
2039
19109
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
27
191
1.32
0.68
1.4
1.4
umol/l
76.3
94.1
0.34
21
106
(3036071) Salmonella sp Ab [Titer] in Serum
7
113
0.58
0.67
1.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
46
350
1.23
0.67
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
46
350
1.23
0.67
1.2
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
19
127
1.40
0.66
1.2
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
41
1.60
0.65
1.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
14
189
0.69
0.65
2.3
1.9
mmol/l
1.5
0.6
0.36
14
175
(3052592) Norovirus Ag [Presence] in Stool
22
152
1.35
0.64
1.3
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
37
276
1.26
0.64
1.0
1.1
mg/l
56.5
46.8
0.51
31
229
(3048879) Bone marrow aspiration report
18
231
0.73
0.63
1.0
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
123
0.61
0.63
1.3
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
112
927
1.13
0.62
1.2
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
33
386
0.80
0.61
2.3
2.4
—
—
—
0
0
(3027874) Urate [Moles/volume] in Urine
0
19
0.00
0.60
0.0
1.1
—
1.7
—
0
12
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
19
0.00
0.60
0.0
13.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
75
607
1.16
0.58
1.1
1.3
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
7
106
0.62
0.58
1.3
1.2
—
95.0
—
0
17
(3044290) Cell count panel - Cerebral spinal fluid
87
927
0.88
0.58
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
323
2829
1.07
0.57
1.7
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
320
0.79
0.56
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
52
410
1.19
0.56
2.5
2.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
44
492
0.84
0.54
1.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
174
1775
0.92
0.54
3.0
3.1
nmol/l
0.8
0.8
0.07
135
1335
(3016244) Insulin [Units/volume] in Serum or Plasma
10
138
0.68
0.54
3.7
2.6
mu/l
11.1
17.3
—
10
129
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
92
762
1.13
0.53
1.9
2.4
u/ml
6324.3
2291.9
—
10
58
(3011985) Renin [Units/volume] in Plasma
61
661
0.86
0.53
1.4
1.3
mu/l
137.4
59.8
0.70
49
581
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
93
1.41
0.52
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
35
397
0.82
0.51
2.3
1.9
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
34
261
1.22
0.49
1.0
1.1
mg/l
386.1
312.7
0.71
29
221
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
71
582
1.14
0.49
1.1
1.2
u/ml
5.9
3.7
0.40
22
173
(3020779) Urea [Moles/volume] in Serum or Plasma
722
6508
1.04
0.48
4.4
6.5
mmol/l
9.2
11.8
16.67
671
6084
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
585
5699
0.96
0.47
2.0
2.1
g/l
0.2
0.2
0.01
540
5192
(3023410) Appearance of Cerebral spinal fluid
52
419
1.16
0.46
1.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
238
0.79
0.45
1.8
1.3
u/l
10.8
25.9
—
6
79
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
79
0.59
0.45
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
113
0.66
0.45
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
132
0.71
0.44
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
31
349
0.83
0.44
1.2
1.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
28
318
0.82
0.43
1.7
2.1
mmol/l
7.8
9.5
1.53
22
255
(3029075) Extractable nuclear Ab panel - Serum
9
120
0.70
0.43
1.1
1.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
85
713
1.12
0.43
1.2
1.6
g/l
0.7
0.9
0.44
55
531
(3033799) Differential panel - Peritoneal fluid
17
204
0.78
0.42
2.2
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
42
457
0.86
0.41
1.3
1.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
14
0.00
0.41
0.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
14
0.00
0.41
0.0
1.7
—
2.5
—
0
8
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
12634.7
—
0
6
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
16
0.00
0.41
0.0
1.1
—
8.3
—
0
16
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
31
242
1.20
0.40
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
287
2544
1.06
0.40
1.2
1.3
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
59
487
1.13
0.40
1.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
253
0.81
0.39
1.4
1.8
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.39
0.0
1.1
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
18
0.00
0.39
0.0
1.1
—
1.3
—
0
18
(3036525) Urea [Moles/time] in 24 hour Urine
5
33
1.42
0.39
4.0
3.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
192
1.22
0.38
1.5
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
223
2212
0.94
0.38
1.2
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
61
507
1.13
0.38
1.1
1.2
%
124.5
112.5
1.91
56
443
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
64
1.32
0.37
2.3
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
64
1.32
0.37
1.3
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
17
200
0.79
0.37
1.9
1.8
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
37
402
0.86
0.37
1.1
1.1
u/ml
61.0
92.5
—
5
14
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
67
561
1.12
0.37
1.2
1.2
u/ml
4.7
4.7
0.02
27
242
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
107
0.70
0.37
1.5
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
33
262
1.18
0.37
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
291
0.84
0.36
1.2
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
60
500
1.12
0.36
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
33
360
0.86
0.35
1.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
71
734
0.90
0.34
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
430
4178
0.96
0.34
1.3
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
109
941
1.08
0.34
1.1
1.2
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
13
93
1.31
0.34
1.0
1.2
—
9.8
—
0
6
(44806071)
6
42
1.34
0.34
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
230
1.18
0.33
1.2
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
17
127
1.25
0.33
1.3
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
11
135
0.76
0.33
1.0
1.1
%
108.8
91.3
1.25
11
99
(3009871) Measles virus Ab [Titer] in Serum
6
81
0.69
0.33
1.3
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
23
257
0.84
0.33
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
85
0.66
0.32
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
82
838
0.91
0.32
1.2
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
50
524
0.89
0.32
2.9
3.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
416
4035
0.96
0.31
1.3
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
91
0.72
0.31
1.0
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
36
384
0.88
0.30
2.3
2.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
12
143
0.78
0.30
1.0
1.1
—
9.3
—
0
15
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
143
0.78
0.30
1.1
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
17
194
0.82
0.30
2.1
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
364
0.87
0.30
1.2
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
132
0.78
0.29
1.5
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
65
667
0.91
0.29
1.2
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
32
343
0.87
0.29
1.3
1.3
promille
1.4
1.1
0.46
24
261
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
92
929
0.93
0.29
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
53
1.24
0.29
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
28
303
0.86
0.29
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
28
303
0.86
0.29
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
28
303
0.86
0.29
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
1449
13332
1.02
0.28
2.7
3.0
mosm/kgh2o
542.8
559.1
2.10
1266
11351
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1091
10403
0.98
0.28
2.9
3.3
e6/l
2.6
1.7
1.97
606
6037
(3045683) HLA typing for celiac disease panel - Blood or Tissue
21
165
1.19
0.28
1.0
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
192
0.83
0.28
1.1
1.2
ratio
1.1
1.1
—
5
57
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
8
59
1.27
0.27
6.0
4.3
ug/min
76.8
62.5
—
8
49
(40757373) Influenza virus identified in Isolate
13
151
0.80
0.27
1.2
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
11
80
1.29
0.26
1.6
1.5
umol/l
43.5
44.4
0.03
11
80
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
18
201
0.84
0.26
1.0
1.1
iu/ml
6.4
12.5
—
8
52
(3001729) Color of Synovial fluid
8
62
1.21
0.26
1.1
1.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
77
665
1.08
0.26
1.2
1.3
nmol/l
0.2
0.3
—
7
47
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
140
0.80
0.26
1.2
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
8
63
1.19
0.26
1.6
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
119
0.79
0.25
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
28
299
0.88
0.25
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
299
0.88
0.25
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
299
0.88
0.25
1.1
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
91
912
0.93
0.25
5.1
6.2
mg/l
11.8
12.3
0.41
84
822
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
255
1.14
0.25
1.2
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
27
289
0.87
0.25
2.2
2.3
ml
1657.9
1865.2
0.52
21
237
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
29
238
1.14
0.24
2.7
2.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
11
128
0.80
0.24
1.3
1.9
%
178.5
208.3
0.76
11
116
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
80
0.70
0.24
1.2
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
15
116
1.21
0.23
8.6
12.2
nmol/l
1024.0
796.7
0.62
15
110
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
35
1.34
0.23
2.4
10.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
31
257
1.13
0.23
3.4
6.4
—
—
—
0
0
(44813793)
22
237
0.87
0.22
1.1
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
17
187
0.85
0.22
2.5
2.4
—
31.0
—
0
5
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
38
1.23
0.22
1.0
1.1
—
13.0
—
0
7
(3016650) Hepatitis A virus Ab [Presence] in Serum
66
665
0.93
0.22
1.0
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
71
618
1.08
0.22
1.1
1.1
g/l
1.6
1.6
0.59
64
547
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
4.5
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
42
357
1.10
0.21
2.9
5.0
u/ml
80.6
39.1
0.34
12
95
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
2.4
—
3.0
—
0
11
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
1519.1
—
0
11
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(3041672) Baker's yeast Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1977
18690
0.99
0.21
4.3
2.5
u/l
59.7
59.6
0.03
1847
17165
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
146
0.83
0.21
1.0
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
97
0.77
0.21
1.0
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
12
0.00
0.21
0.0
4.9
—
362.3
—
0
12
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
38.0
—
0
5
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.4
—
2.1
—
0
12
(40763590) HLA-DQ beta [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(4268621)
36
372
0.90
0.20
2.0
2.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
13
0.00
0.20
0.0
1.4
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
13
0.00
0.20
0.0
6.3
—
42.5
—
0
13
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
156
1397
1.05
0.20
1.5
1.6
iu/ml
63.0
14.5
0.36
47
356
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
125
0.82
0.20
1.7
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
465
4453
0.98
0.20
1.7
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1224
11605
0.98
0.20
1.6
1.7
mg/l
1.9
1.6
1.72
1009
9067
(3004616) Nuclear Ab [Presence] in Serum
60
603
0.93
0.19
1.3
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
95
939
0.95
0.19
1.2
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
32
331
0.90
0.19
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
16
128
1.17
0.19
1.1
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
77
764
0.94
0.18
1.2
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
56
1.17
0.18
1.1
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
79
782
0.94
0.17
1.2
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
64
0.73
0.17
1.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
65
0.72
0.17
1.8
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
112
0.83
0.16
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
78
769
0.95
0.16
1.2
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
53
529
0.94
0.15
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
35
302
1.08
0.14
1.2
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
20
208
0.90
0.14
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
249
1.09
0.13
1.2
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
15
159
0.88
0.13
1.3
1.6
g/l
12.8
14.4
—
10
123
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
141
1.13
0.13
1.3
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
18
188
0.90
0.13
1.2
1.2
—
—
—
0
0
(4281824)
46
458
0.94
0.13
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
39
341
1.07
0.12
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
35
305
1.07
0.12
1.2
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
35
306
1.07
0.11
1.2
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
106
1026
0.97
0.11
3.1
2.6
—
—
—
0
0
(4133840)
12
98
1.15
0.11
1.5
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
36
359
0.94
0.11
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
16
166
0.90
0.10
1.1
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
117
0.88
0.10
1.2
1.9
ug/l
0.9
1.2
0.48
11
109
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
117
0.88
0.10
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
59
528
1.05
0.10
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
14
117
1.12
0.10
1.4
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
108
1041
0.97
0.10
3.0
2.6
mmol/l
4.1
4.1
0.21
108
1029
(3035285) Chloride [Moles/volume] in Venous blood
108
1041
0.97
0.10
3.0
2.6
mmol/l
104.1
105.7
2.97
108
1029
(3016879) Cocaine [Presence] in Urine
32
281
1.07
0.09
1.3
1.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
161
1471
1.02
0.09
2.8
2.7
mg/l
1.5
1.8
5.69
150
1303
(3024928) Oxygen saturation in Venous blood
147
1409
0.98
0.09
1.9
2.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
22
222
0.93
0.09
1.5
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
73
707
0.97
0.08
1.2
1.4
u/ml
146.2
122.8
0.29
19
149
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
53
1.06
0.08
1.0
1.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
57
0.82
0.08
1.2
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
7
62
1.06
0.08
3.3
2.2
—
72.2
—
0
11
(3023511) Choriogonadotropin [Units/volume] in Urine
8
69
1.08
0.07
1.1
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
105
0.89
0.07
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
24
239
0.94
0.07
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
24
239
0.94
0.07
1.0
1.0
—
—
—
0
0
(3020891) Body temperature
296
2805
0.99
0.07
4.9
4.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
20
174
1.08
0.07
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
200
0.94
0.06
1.1
1.1
u/l
1.0
1.2
0.93
11
99
(3002523) Influenza virus A Ag [Presence] in Specimen
38
341
1.04
0.06
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
33
295
1.05
0.06
1.3
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
34
332
0.96
0.06
1.4
1.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
130
1.08
0.05
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
80
765
0.98
0.05
1.2
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
148
1364
1.02
0.05
1.9
3.1
u/ml
162.4
795.1
2.05
133
1248
(3002032) Base excess in Venous blood by calculation
712
6696
0.99
0.04
3.3
3.7
mmol/l
2.4
1.8
3.36
595
5325
(3042733) HLA Ab [Presence] in Serum
10
102
0.92
0.04
2.4
4.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
80
762
0.98
0.03
1.2
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
258
2394
1.01
0.03
1.2
1.3
u/ml
274.3
246.3
0.24
232
2179
(3038177) Helicobacter pylori Ab [Presence] in Serum
60
573
0.98
0.03
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
80
761
0.98
0.03
1.2
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
51
467
1.02
0.02
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1146
10744
1.00
0.02
5.4
4.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
42
384
1.02
0.02
2.5
2.1
ug/min
94.4
156.9
—
8
91
(4306422)
57
524
1.02
0.02
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
715
6701
1.00
0.01
3.3
3.7
kpa
6.0
5.8
2.31
687
6447
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
137
0.96
0.01
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
942
8821
1.00
0.01
4.1
5.5
mmol/l
1.0
1.0
0.78
877
8033
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
124
0.98
0.00
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
47
443
0.99
0.00
1.3
1.8
%
11.5
10.7
0.47
47
443
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
28
260
1.01
0.00
1.1
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
129
1.02
0.00
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
14
134
0.98
0.00
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
62
582
1.00
0.00
1.2
1.3
nmol/l
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
21
194
1.01
0.00
1.2
1.1
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
50
0.94
0.00
1.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.8
—
14.0
—
0
5
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
76
0.98
0.00
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
65
0.86
0.00
1.2
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
59
0.95
0.00
1.3
1.6
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
9
89
0.95
0.00
2.4
2.4
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
78
0.96
0.00
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
54
0.87
0.00
1.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
8
76
0.98
0.00
1.1
1.1
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
3230.0
—
0
6
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
5
54
0.87
0.00
1.0
1.1
—
31.9
—
0
14
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
79
0.95
0.00
1.1
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
9
0.00
0.00
0.0
6.4
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
57
0.98
0.00
1.0
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BRONCHUS_LUNG – Malignant neoplasm of bronchus and lung
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).